<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Funct Morphol Kinesiol</journal-id><journal-id journal-id-type="iso-abbrev">J Funct Morphol Kinesiol</journal-id><journal-id journal-id-type="publisher-id">jfmk</journal-id><journal-title-group><journal-title>Journal of Functional Morphology and Kinesiology</journal-title></journal-title-group><issn pub-type="epub">2411-5142</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407454</article-id><article-id pub-id-type="pmc">PMC12101153</article-id>
<article-id pub-id-type="doi">10.3390/jfmk10020170</article-id><article-id pub-id-type="publisher-id">jfmk-10-00170</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Aquatic Therapy Versus Land-Based Therapy in Patients with Parkinson&#x02019;s Disease: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6521-2053</contrib-id><name><surname>Santamar&#x000ed;a</surname><given-names>Gema</given-names></name><xref rid="af1-jfmk-10-00170" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8216-9472</contrib-id><name><surname>Fern&#x000e1;ndez-Gorgojo</surname><given-names>Mario</given-names></name><xref rid="af2-jfmk-10-00170" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2612-934X</contrib-id><name><surname>Guti&#x000e9;rrez-Abej&#x000f3;n</surname><given-names>Eduardo</given-names></name><xref rid="af3-jfmk-10-00170" ref-type="aff">3</xref><xref rid="af4-jfmk-10-00170" ref-type="aff">4</xref><xref rid="af5-jfmk-10-00170" ref-type="aff">5</xref><xref rid="af6-jfmk-10-00170" ref-type="aff">6</xref><xref rid="af7-jfmk-10-00170" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2264-2285</contrib-id><name><surname>Garc&#x000ed;a G&#x000f3;mez</surname><given-names>Blanca</given-names></name><xref rid="af8-jfmk-10-00170" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0004-5684-9406</contrib-id><name><surname>Molina</surname><given-names>&#x000c1;ngela</given-names></name><xref rid="af9-jfmk-10-00170" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6522-8896</contrib-id><name><surname>Fern&#x000e1;ndez-L&#x000e1;zaro</surname><given-names>Diego</given-names></name><xref rid="af10-jfmk-10-00170" ref-type="aff">10</xref><xref rid="c1-jfmk-10-00170" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Hortob&#x000e1;gyi</surname><given-names>Tibor</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jfmk-10-00170"><label>1</label>Department of Anatomy and Radiology, Faculty of Health Sciences, Campus of Soria, University of Valladolid, 42003 Soria, Spain; <email>gema.santamaria@uva.es</email></aff><aff id="af2-jfmk-10-00170"><label>2</label>Faculty of Health Sciences, Campus of Ponferrada, University of Le&#x000f3;n, 24416 Ponferrada, Spain; <email>mafeg@unileon.es</email></aff><aff id="af3-jfmk-10-00170"><label>3</label>Pharmacological Big Data Laboratory, Department of Cell Biology, Genetics, Histology and Pharmacology, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain; <email>egutierreza@saludcastillayleon.es</email></aff><aff id="af4-jfmk-10-00170"><label>4</label>BioCritic, Group for Biomedical Research in Critical Care Medicine, 47003 Valladolid, Spain</aff><aff id="af5-jfmk-10-00170"><label>5</label>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain</aff><aff id="af6-jfmk-10-00170"><label>6</label>Pharmacy Directorate, Castilla y Le&#x000f3;n Health Council, 47007 Valladolid, Spain</aff><aff id="af7-jfmk-10-00170"><label>7</label>Valladolid Este Primary Care Department, 47010 Valladolid, Spain</aff><aff id="af8-jfmk-10-00170"><label>8</label>Department of Business Organization and Marketing and Market Research, Faculty of Business and Labor Sciences, University of Valladolid, Campus of Soria, 42004 Soria, Spain; <email>blanca.garcia.gomez@uva.es</email></aff><aff id="af9-jfmk-10-00170"><label>9</label>Faculty of Chemistry, Rovira and Virgili University, 43007 Tarragona, Spain; <email>angela.molina@estudiants.urv.cat</email></aff><aff id="af10-jfmk-10-00170"><label>10</label>Area of Histology and Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain</aff><author-notes><corresp id="c1-jfmk-10-00170"><label>*</label>Correspondence: <email>diego.fernandez.lazaro@uva.es</email></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>170</elocation-id><history><date date-type="received"><day>01</day><month>4</month><year>2025</year></date><date date-type="rev-recd"><day>05</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>06</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background:</bold> Parkinson&#x02019;s Disease (PD) is the second most prevalent neurodegenerative disease worldwide. Motor and non-motor symptoms of PD cause functional disabilities. Aquatic-based therapeutic exercise (AT) is a potential approach that may improve the management of PD, given its hydrostatic and hydrodynamic properties. We aimed to evaluate the effectiveness and safety of AT compared to traditional land-based therapeutic exercise (LT) in patients with PD. <bold>Methods:</bold> Based on the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, we systematically reviewed studies indexed in PubMed, Scopus, Web of Science, PEDro, CINAHL, and Cochrane. Registered in PROSPERO (CRD42024528310), this review involved original studies published from 2014 to December 2024, with a randomized controlled trial (RCT) design, in which the intervention group performed AT, and the control group performed LT. The outcomes evaluated were balance, gait, quality of life, strength, mental health, pain, flexibility, and sleep quality. <bold>Results:</bold> Of the 413 records identified, 135 duplicates were removed, and 265 did not meet the selection criteria. Thirteen RCTs comprising 511 patients (age range: 50&#x02013;80 years) were eligible. Most studies reported beneficial effects of AT, with no serious adverse events. Compared to LT, AT led to significant improvements (<italic toggle="yes">p</italic> &#x0003c; 0.05) in quality of life, mental health, pain, flexibility, and sleep quality. No evidence was provided of the beneficial effects of AT compared to LT on balance, gait, and strength; however, significant improvements were observed in the AT group from baseline (<italic toggle="yes">p</italic> &#x0003c; 0.05). <bold>Conclusions:</bold> AT appears to be a safe and effective intervention for improving the quality of life, mental health, pain, flexibility, and sleep quality in PD patients. While balance, gait, and strength may also benefit, the evidence comparing AT to LT remains inconclusive due to variability in study protocols.</p></abstract><kwd-group><kwd>Parkinson&#x02019;s disease</kwd><kwd>aquatic therapy</kwd><kwd>land-based therapy</kwd><kwd>quality of life</kwd><kwd>balance</kwd></kwd-group><funding-group><award-group><funding-source>Department of Education of the Junta de Castilla&#x02014;Le&#x000f3;n and the European Regional Development Fund (FEDER) by TCUE Plan 20242027</funding-source><award-id>067/230003</award-id></award-group><funding-statement>This study has been financed by the Department of Education of the Junta de Castilla&#x02014;Le&#x000f3;n and the European Regional Development Fund (FEDER) by TCUE Plan 20242027, approved in the Order of 16 September 2024, grant no. 067/230003).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-jfmk-10-00170"><title>1. Introduction</title><p>Parkinson&#x02019;s disease (PD) is a multisystem neurodegenerative disease characterized by deposits of &#x003b1;-synuclein in multiple regions of the nervous system [<xref rid="B1-jfmk-10-00170" ref-type="bibr">1</xref>,<xref rid="B2-jfmk-10-00170" ref-type="bibr">2</xref>]. The main regions are the substantia nigra, nucleus basalis of Meynert, and dorsal motor nucleus of the vagus nerve [<xref rid="B2-jfmk-10-00170" ref-type="bibr">2</xref>,<xref rid="B3-jfmk-10-00170" ref-type="bibr">3</xref>]. Patients with PD exhibit motor symptoms such as resting tremors, bradykinesia, stiffness, postural instability, and postural and gait alterations [<xref rid="B1-jfmk-10-00170" ref-type="bibr">1</xref>,<xref rid="B2-jfmk-10-00170" ref-type="bibr">2</xref>,<xref rid="B4-jfmk-10-00170" ref-type="bibr">4</xref>]. Non-motor symptoms, although often underestimated, can be equally disruptive motor symptoms, severely affecting patients&#x02019; quality of life (QoL) and autonomy [<xref rid="B4-jfmk-10-00170" ref-type="bibr">4</xref>]. These include fatigue, sleep disturbance, depression, anxiety, cognitive impairment, dementia, hallucinations, urinary problems, and sexual dysfunction [<xref rid="B2-jfmk-10-00170" ref-type="bibr">2</xref>,<xref rid="B3-jfmk-10-00170" ref-type="bibr">3</xref>,<xref rid="B4-jfmk-10-00170" ref-type="bibr">4</xref>,<xref rid="B5-jfmk-10-00170" ref-type="bibr">5</xref>]. PD has become one of the main causes of disability worldwide, being the second most prevalent neurodegenerative disease after Alzheimer&#x02019;s Disease [<xref rid="B6-jfmk-10-00170" ref-type="bibr">6</xref>]. The prevalence of PD in industrialized countries is estimated to be 0.3%, affecting up to 3% of the population over 80 years old [<xref rid="B2-jfmk-10-00170" ref-type="bibr">2</xref>]. PD is experiencing an alarming global increase, from 2.5 million cases in 1990 to 6.1 million in 2016, and these rates are expected to double by 2030 [<xref rid="B1-jfmk-10-00170" ref-type="bibr">1</xref>,<xref rid="B3-jfmk-10-00170" ref-type="bibr">3</xref>]. This high increase has led some researchers to characterize PD as a pandemic due to its wide geographical spread and exponential growth [<xref rid="B7-jfmk-10-00170" ref-type="bibr">7</xref>,<xref rid="B8-jfmk-10-00170" ref-type="bibr">8</xref>]. PD has a considerable impact on public health and the global economy. The United States spent USD 14.4 billion in 2010 on PD treatment, equivalent to USD 22,800 per patient [<xref rid="B9-jfmk-10-00170" ref-type="bibr">9</xref>]. For all these reasons, PD has become a major public health problem requiring an urgent solution.</p><p>Despite advances in the understanding of PD, there is currently no treatment able to stop or reverse the neurodegenerative process [<xref rid="B1-jfmk-10-00170" ref-type="bibr">1</xref>]. Conventional treatment is focused on symptom control, mainly through the administration of levodopa in combination with carbidopa [<xref rid="B1-jfmk-10-00170" ref-type="bibr">1</xref>,<xref rid="B2-jfmk-10-00170" ref-type="bibr">2</xref>]. Although this drug therapy has increased survival from 9 to 13 years [<xref rid="B2-jfmk-10-00170" ref-type="bibr">2</xref>], side effects such as fatigue, dyskinesias, anxiety, and somnolence are common and can complicate the management of the disease [<xref rid="B4-jfmk-10-00170" ref-type="bibr">4</xref>]. In order to reduce doses and modulate side effects, therapeutic exercise has been proposed as a possible adjuvant [<xref rid="B10-jfmk-10-00170" ref-type="bibr">10</xref>,<xref rid="B11-jfmk-10-00170" ref-type="bibr">11</xref>,<xref rid="B12-jfmk-10-00170" ref-type="bibr">12</xref>,<xref rid="B13-jfmk-10-00170" ref-type="bibr">13</xref>,<xref rid="B14-jfmk-10-00170" ref-type="bibr">14</xref>]. In particular, aquatic therapy (AT) has emerged as an alternative therapeutic option due to water properties like floatability, hydrostatic pressure, viscosity, and thermodynamics [<xref rid="B15-jfmk-10-00170" ref-type="bibr">15</xref>,<xref rid="B16-jfmk-10-00170" ref-type="bibr">16</xref>]. AT is considered a non-invasive, non-pharmacological treatment for chronic diseases [<xref rid="B17-jfmk-10-00170" ref-type="bibr">17</xref>,<xref rid="B18-jfmk-10-00170" ref-type="bibr">18</xref>]. AT has been shown to significantly improve balance, gait, strength, and QoL in patients with PD [<xref rid="B19-jfmk-10-00170" ref-type="bibr">19</xref>,<xref rid="B20-jfmk-10-00170" ref-type="bibr">20</xref>,<xref rid="B21-jfmk-10-00170" ref-type="bibr">21</xref>]. However, there is no consensus on the effectiveness of AT compared to land-based therapeutic exercise (LT). Some authors argue that AT provides greater benefits than LT [<xref rid="B20-jfmk-10-00170" ref-type="bibr">20</xref>,<xref rid="B22-jfmk-10-00170" ref-type="bibr">22</xref>,<xref rid="B23-jfmk-10-00170" ref-type="bibr">23</xref>], while others recognize its benefits but do not consider AT superior to LT [<xref rid="B19-jfmk-10-00170" ref-type="bibr">19</xref>,<xref rid="B24-jfmk-10-00170" ref-type="bibr">24</xref>]. The effectiveness of AT in PD has been the subject of several reviews in the scientific literature [<xref rid="B20-jfmk-10-00170" ref-type="bibr">20</xref>,<xref rid="B21-jfmk-10-00170" ref-type="bibr">21</xref>,<xref rid="B23-jfmk-10-00170" ref-type="bibr">23</xref>,<xref rid="B24-jfmk-10-00170" ref-type="bibr">24</xref>,<xref rid="B25-jfmk-10-00170" ref-type="bibr">25</xref>,<xref rid="B26-jfmk-10-00170" ref-type="bibr">26</xref>]. However, these reviews have highlighted substantial limitations, including small sample size [<xref rid="B21-jfmk-10-00170" ref-type="bibr">21</xref>,<xref rid="B24-jfmk-10-00170" ref-type="bibr">24</xref>], inclusion of uncontrolled clinical trials [<xref rid="B25-jfmk-10-00170" ref-type="bibr">25</xref>], and control group heterogeneity [<xref rid="B20-jfmk-10-00170" ref-type="bibr">20</xref>,<xref rid="B23-jfmk-10-00170" ref-type="bibr">23</xref>,<xref rid="B26-jfmk-10-00170" ref-type="bibr">26</xref>]. These methodological shortcomings underline the need for a rigorous systematic review that addresses the current evidence and provides a critical assessment of the effectiveness of AT compared to LT. In this context, the aim of the present study was to systematically review the available scientific evidence on the effectiveness of AT compared to LT in patients with PD, analyzing aspects such as QoL, balance, gait, and strength.</p></sec><sec id="sec2-jfmk-10-00170"><title>2. Materials and Methods</title><p>The present systematic review was conducted and reported following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines [<xref rid="B27-jfmk-10-00170" ref-type="bibr">27</xref>] (<xref rid="app1-jfmk-10-00170" ref-type="app">Appendix A</xref>). The systematic review protocol was registered in PROSPERO (CRD42024528310).</p><sec id="sec2dot1-jfmk-10-00170"><title>2.1. Search Strategy</title><p>The PICO question model was used according to the recommendations of Evidence-Based Medicine [<xref rid="B28-jfmk-10-00170" ref-type="bibr">28</xref>]: P (population): men and women diagnosed with PD classified within stages 1&#x02013;3 on the Hoehn and Yahr Scale (H&#x00026;Y), excluding patients with dementia, cognitive impairments, cardiac pathologies, or other associated conditions. I (intervention): aquatic-based therapeutic exercise. C (comparison): land-based therapy. O (outcomes): balance, gait, QoL, strength, pain, flexibility, mental health, and sleep quality. S (study design): randomized clinical trial. For article selection, a structured search was carried out using the electronic databases Medline (PubMed), Scopus, Web of Science, Physiotherapy Evidence Database (PEDro), CINAHL, and Cochrane between October and December 2024. The search strategy, detailed in <xref rid="app2-jfmk-10-00170" ref-type="app">Appendix B</xref>, contained a combination of Medical Subject Headings (MeSH) and free words such as &#x0201c;Parkinson Disease&#x0201d;, &#x0201c;Parkinson&#x0201d;, &#x0201c;Parinson&#x02019;s Disease&#x0201d;, &#x0201c;Aquatic Therapy&#x0201d;, &#x0201c;Aquatic Exercise Therapy&#x0201d;, &#x0201c;Water Exercise Therapy&#x0201d;, and &#x0201c;Ai Chi Therapy&#x0201d; linked by the Boolean operators &#x0201c;AND&#x0201d; and &#x0201c;OR&#x0201d;. Two authors independently performed the search for published studies, and a third reviewer participated in case of disagreement. In addition, the bibliographic references of all included articles and some of the excluded articles were reviewed, and ResearchGate was checked in order to identify relevant titles that might have been missed by the search strategy.</p></sec><sec id="sec2dot2-jfmk-10-00170"><title>2.2. Selection Criteria</title><p>The following inclusion criteria were established for the studies selection: (1) Patients with PD (excluding studies whose population had other associated pathologies); (2) Intervention group (IG) treated with AT; (3) Control group (CG) treated with LT; (4) Randomized clinical trials that report primary or secondary outcomes on QoL, balance, gait, strength, flexibility, pain, sleep quality, or mental health; (5) Score equal to or greater than 6 on the Critical Appraisal Skills Program in Spanish (CASPe) questionnaire [<xref rid="B29-jfmk-10-00170" ref-type="bibr">29</xref>]; (6) Published in Spanish, English, Italian and Portuguese; (7) Published from 2014 onwards.</p><p>All studies that did not meet these criteria were excluded.</p></sec><sec id="sec2dot3-jfmk-10-00170"><title>2.3. Data Extraction</title><p>The first author&#x02019;s surname, year of publication, country of publication, sample size, gender, age, intervention of IG and CG, measurement scales used, and final results were extracted from all included studies. The data extraction process was independently carried out by two researchers using a spreadsheet (Microsoft Inc., Seattle, WA, USA). In case of disagreements, a third reviewer was involved in this process.</p></sec><sec id="sec2dot4-jfmk-10-00170"><title>2.4. Assessment of Methodological Quality and Risk of Bias</title><p>The CASPe questionnaire [<xref rid="B29-jfmk-10-00170" ref-type="bibr">29</xref>] was used to assess the methodological quality of the included studies. Additionally, the risk of bias was assessed using the Cochrane risk of bias tool [<xref rid="B30-jfmk-10-00170" ref-type="bibr">30</xref>].</p></sec></sec><sec sec-type="results" id="sec3-jfmk-10-00170"><title>3. Results</title><sec id="sec3dot1-jfmk-10-00170"><title>3.1. Study Selection</title><p>The literature search resulted in a total of 413 records from Medline (<italic toggle="yes">n</italic> = 94), PEDro (<italic toggle="yes">n</italic> = 28), Cochrane (<italic toggle="yes">n</italic> = 35), Scopus (<italic toggle="yes">n</italic> = 35), Web of Science (<italic toggle="yes">n</italic> = 189), and CINAHL (<italic toggle="yes">n</italic> = 32). No eligible studies were identified in ResearchGate or the reference list of relevant studies. After duplicate removal (<italic toggle="yes">n</italic> = 135), the titles and abstracts of the remaining 278 publications were analyzed. A total of 265 publications were eliminated for not being related to the topic of interest (<italic toggle="yes">n</italic> = 181), not being randomized clinical trials (<italic toggle="yes">n</italic> = 63), having been published prior to 2014 (<italic toggle="yes">n</italic> = 6), having a CG who did not perform LT (<italic toggle="yes">n</italic> = 8), being protocols without results (<italic toggle="yes">n</italic> = 5), and being in a language other than English, Spanish, Italian, and Portuguese (<italic toggle="yes">n</italic> = 2). The remaining 13 trials were examined in full text and met the selection criteria for inclusion in the systematic review [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] (<xref rid="jfmk-10-00170-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec3dot2-jfmk-10-00170"><title>3.2. Assessment of Methodological Quality</title><p>All included articles met the minimum requirements for methodological quality, scoring above 6 on the CASPe questionnaire [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. Scores ranged from 8 [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>] to 10 points [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>]. Due to the type of intervention, none of the trials met the criterion of complete blinding. All therapists and participants knew the group to which they had been assigned [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. However, in nine studies, the assessors were blinded [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. The effect sizes were large (d = 0.8) [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], medium (0.5 &#x0003c; d &#x0003c; 0.8) [<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], and small (d &#x0003c; 0.5) [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>] (<xref rid="jfmk-10-00170-t001" ref-type="table">Table 1</xref>).</p></sec><sec sec-type="subjects" id="sec3dot3-jfmk-10-00170"><title>3.3. Characteristics of Participants and Interventions</title><p>The total initial number of volunteers was 511, of which 464 completed this study, representing a dropout rate of 9.19% [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. A total of 64% of the participants were men, and 36% were women between the ages of 50 and 80 years [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. All studies included men and women in their samples [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], except Shahmohammadi et al. [<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>], who only included men. Participants had PD stages 1&#x02013;3 on the H&#x00026;Y scale [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], 2&#x02013;3 H&#x00026;Y [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>], and 2.5&#x02013;3 H&#x00026;Y [<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. The investigation was conducted during ON [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] or OFF [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>] periods of medication (<xref rid="jfmk-10-00170-t002" ref-type="table">Table 2</xref>).</p><p><xref rid="jfmk-10-00170-t003" ref-type="table">Table 3</xref> shows the characteristics of the interventions. Ten studies proposed the same protocol duration and frequency, duration, and intensity of the sessions for the IG and the CG, differing only in the type of exercise performed [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]. In the remaining three studies [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], the IG performed the same LT program as the CG in addition to AT. The duration of the protocols varied from 4 [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] to 12 weeks [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]. Each week, one [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>], two [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], three [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], or five [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>] sessions were performed. The duration of the session ranged from 30 [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>] to 60 min [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. All sessions were supervised by a qualified professional [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. The techniques used in the main part were Ai Chi [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>], WATSU [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>], Halliwick [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>], gait work [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], balance [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], proprioception [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], coordination [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], strength work [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], aerobic work [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>], and joint mobility [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>].</p></sec><sec id="sec3dot4-jfmk-10-00170"><title>3.4. Evaluation of the Results</title><p>The parameters assessed and the results obtained after the interventions are presented in <xref rid="jfmk-10-00170-t002" ref-type="table">Table 2</xref>. In addition, the main findings are summarized in <xref rid="jfmk-10-00170-f002" ref-type="fig">Figure 2</xref>.</p><sec id="sec3dot4dot1-jfmk-10-00170"><title>3.4.1. Balance</title><p>Changes in balance were assessed by 10 of the studies included in this systematic review [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. The 10 trials found statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) improvements in IG balance from baseline [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. However, only five of them reported statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) improvements over CG [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>], while the remaining five did not find any difference (<italic toggle="yes">p</italic> &#x0003e; 0.05) [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>].</p></sec><sec id="sec3dot4dot2-jfmk-10-00170"><title>3.4.2. Gait</title><p>Nine of the 13 included studies evaluated the effects of AT on gait [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. All studies, with the exception of Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>], reported statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) improvements in IG gait from baseline [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. A greater disparity has been observed in relation to changes in IG compared to CG. Three studies reported significant improvements (<italic toggle="yes">p</italic> &#x0003c; 0.05) [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>] in contrast to the remaining six studies, which showed no differences between groups (<italic toggle="yes">p</italic> &#x0003e; 0.05) [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>].</p></sec><sec id="sec3dot4dot3-jfmk-10-00170"><title>3.4.3. Quality of Life</title><p>QoL related to PD symptomatology has been the most studied parameter, assessed by all 13 studies [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. Ten of the studies recorded statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) increases in the IG compared to baseline [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. However, only seven of them found better results in IG (<italic toggle="yes">p</italic> &#x0003c; 0.05) than in CG [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>], while the remaining six did not show significant differences (<italic toggle="yes">p</italic> &#x0003e; 0.05) [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>].</p></sec><sec id="sec3dot4dot4-jfmk-10-00170"><title>3.4.4. Strength</title><p>Lower limb strength was assessed by four trials using the Sit-to-stand test [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]. Three of them found statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) increases in IG over baseline [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], but only P&#x000e9;rez de la Cruz [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>] reported statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) increases over CG. In a complementary way, Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>] assessed the isometric strength of the knee and ankle musculature and the isokinetic strength of the knee. In none of these parameters, IG was superior to CG (<italic toggle="yes">p</italic> &#x0003e; 0.05) despite significant increases (<italic toggle="yes">p</italic> &#x0003c; 0.05) compared to baseline [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>].</p><p>In addition, Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>] and Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>] assessed upper limb strength with manual dynamometry. The results of the two studies indicate that there are no significant differences (<italic toggle="yes">p</italic> &#x0003e; 0.05) between groups [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>].</p></sec><sec id="sec3dot4dot5-jfmk-10-00170"><title>3.4.5. Other Parameters Evaluated</title><p>The effect of AT on mental health was evaluated by three studies [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]. P&#x000e9;rez de la Cruz [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>] found in his two studies statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) improvements in IG compared to CG, while Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>] did not find differences in IG compared to CG or baseline. Pain was studied by P&#x000e9;rez de la Cruz in his three investigations [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>]. This author reported a statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) reduction in pain in IG relative to CG and baseline in all three studies [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>]. Aerobic capacity was assessed by Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>] and Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>], neither of whom found significant differences between groups (<italic toggle="yes">p</italic> &#x0003e; 0.05). Lower limb flexibility was studied by Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], who reported significant increases (<italic toggle="yes">p</italic> &#x0003c; 0.05) in the IG with respect to the CG and baseline. Finally, Loureiro et al. [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>] evaluated the effect of TA on sleep quality, finding a significant increase (<italic toggle="yes">p</italic> &#x0003c; 0.05) in IG compared to CG and baseline.</p></sec></sec><sec id="sec3dot5-jfmk-10-00170"><title>3.5. Bias Assessment</title><p>The assessment of bias is represented in <xref rid="jfmk-10-00170-t004" ref-type="table">Table 4</xref> and <xref rid="jfmk-10-00170-f003" ref-type="fig">Figure 3</xref> according to Cochrane recommendations [<xref rid="B30-jfmk-10-00170" ref-type="bibr">30</xref>]. All studies showed low risk in random allocation of participants, incomplete outcomes data, and other biases [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. In contrast, all studies were at high risk of blinding participants and therapists [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. Eight of the studies did not specify in the methodology how allocation concealment was performed [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]. The three studies by P&#x000e9;rez de la Cruz [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>] had an unclear risk of selective reporting of results.</p></sec></sec><sec sec-type="discussion" id="sec4-jfmk-10-00170"><title>4. Discussion</title><p>Overall, AT has been demonstrated to be an effective therapeutic approach in improving balance, gait, QoL, strength, pain, mental health, flexibility, and sleep quality. In addition, participants who practiced AT showed significantly (<italic toggle="yes">p</italic> &#x0003c; 0.05) higher improvements in QoL, mental health, flexibility, sleep quality, and pain compared to LT. However, there is no evidence of superior effects of AT on balance, gait, and strength. It is important to note that none of the 13 clinical trials reviewed reported that LT was superior to AT in any of the parameters assessed. Therefore, AT has been shown to be a superior or at least equal alternative to LT in the treatment of PD. No adverse effects of AT practice have been reported in PD patients, demonstrating that AT is a safe therapy [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. To ensure safety, all interventions were supervised by a qualified physiotherapist following Australian Physiotherapy Association guidelines [<xref rid="B44-jfmk-10-00170" ref-type="bibr">44</xref>].</p><sec id="sec4dot1-jfmk-10-00170"><title>4.1. Balance</title><p>Balance disturbances and falls are among the motor symptoms that most concern PD patients, second only to tremors [<xref rid="B45-jfmk-10-00170" ref-type="bibr">45</xref>]. As PD progresses, the processing of vestibular, visual, and proprioceptive signals responsible for maintaining balance becomes impaired [<xref rid="B46-jfmk-10-00170" ref-type="bibr">46</xref>]. In this context, all 10 clinical trials assessing balance reported statistically significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) increases after AT [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. The aquatic environment may compensate for the altered proprioceptive signal processing by acting on peripheral sensory receptors [<xref rid="B47-jfmk-10-00170" ref-type="bibr">47</xref>]. Increased proprioceptive input may contribute to improved balance and body alignment [<xref rid="B47-jfmk-10-00170" ref-type="bibr">47</xref>]. In addition, AT, due to the floatability and viscosity of water, helps to organize the information and response of cortical regions, providing coordinated motor strategies and improving balance [<xref rid="B21-jfmk-10-00170" ref-type="bibr">21</xref>]. Finally, in-water training reduces the fear of falling and allows more challenging balance exercises to be performed for longer periods of time [<xref rid="B48-jfmk-10-00170" ref-type="bibr">48</xref>].</p><p>There is no consensus on the effectiveness of AT compared to LT on balance. Five trials have reported that AT was superior to LT [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>], while the remaining five have found no significant difference between groups [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. The only difference in the protocols used seems to be in water temperature. Authors who found superior AT kept the water at 30&#x02013;32 &#x000b0;C [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>], while authors who did not find a difference maintained it at 34&#x02013;34.7 &#x000b0;C [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>] or did not specify it [<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. Water temperature is an important factor to consider. It has been suggested that warm water may stimulate skin thermoreceptors and increase the activity of cortical sensory and motor areas, promoting sensory-motor integration [<xref rid="B23-jfmk-10-00170" ref-type="bibr">23</xref>]. It would, therefore, have a positive effect on balance. However, it should be noted that warm water also reduces muscle tone. A plausible hypothesis is that excessively hot water drastically reduces the tone of the musculature responsible for maintaining balance, impairing the correct performance of its function. A final point to highlight is that neither of the two studies that added AT to LT found improvements with respect to CG [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. This suggests that practice AT does not provide additional benefits when LT is already being performed.</p></sec><sec id="sec4dot2-jfmk-10-00170"><title>4.2. Gait</title><p>Following AT intervention, gait improved significantly (<italic toggle="yes">p</italic> &#x0003c; 0.05) in eight [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] of the nine studies that assessed it [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. Gait improvement has been reported to be closely related to the balance benefits mentioned above [<xref rid="B49-jfmk-10-00170" ref-type="bibr">49</xref>]. Increasing postural stability allows patients to focus on walking correctly, which reduces the freezing of gait episodes [<xref rid="B49-jfmk-10-00170" ref-type="bibr">49</xref>]. In addition, walking underwater can positively influence motor learning, allowing patients to adapt to environmental perturbations [<xref rid="B50-jfmk-10-00170" ref-type="bibr">50</xref>]. AT achieves changes in spatiotemporal parameters and lower limb kinematics, generating clinically significant effects [<xref rid="B50-jfmk-10-00170" ref-type="bibr">50</xref>]. On the other hand, AT was only superior to LT in trials that used Ai Chi [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>], indicating that it is the most effective methodology in improving gait. A previous systematic review reported that Ai Chi is effective in improving balance, pain, and functional mobility in healthy adults and patients with neurological diseases [<xref rid="B48-jfmk-10-00170" ref-type="bibr">48</xref>]. This is consistent with the results found in this review, especially in relation to gait. Many of the Ai Chi benefits are thought to come from conscious movement, giving it superior effects to LT and other types of AT [<xref rid="B48-jfmk-10-00170" ref-type="bibr">48</xref>].</p><p>Freezing of gait, despite being a very limiting phenomenon and a frequent cause of falls [<xref rid="B51-jfmk-10-00170" ref-type="bibr">51</xref>], has only been evaluated by one study [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>]. Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>] reported that AT significantly (<italic toggle="yes">p</italic> &#x0003c; 0.05) reduces freezing of gait but did not find a difference with LT. In their protocol, Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>] added AT to LT, which might indicate that AT does not bring additional benefits when LT is already performed, as in the case of balance. Considering that the freezing of gait is caused by a loss of sensory information at the central level [<xref rid="B52-jfmk-10-00170" ref-type="bibr">52</xref>], AT could be expected to reduce the freezing of gait by increasing sensory information [<xref rid="B47-jfmk-10-00170" ref-type="bibr">47</xref>]. However, future studies are needed to clarify the effectiveness of AT alone on freezing gait.</p></sec><sec id="sec4dot3-jfmk-10-00170"><title>4.3. Quality of Life</title><p>Participants&#x02019; QoL improved significantly (<italic toggle="yes">p</italic> &#x0003c; 0.05) after AT practice [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. Seven studies have found that TA was superior (<italic toggle="yes">p</italic> &#x0003c; 0.05) to LT in improving QoL [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>], while six studies did not report a difference (<italic toggle="yes">p</italic> &#x0003e; 0.05) [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>]. Similarly, a recent systematic review by Gomes-Neto et al. [<xref rid="B53-jfmk-10-00170" ref-type="bibr">53</xref>] concluded that AT provides greater benefits than LT on QoL. AT could increase the QoL of PD patients for the following four reasons: (1) The improvements in balance and gait discussed in the previous points. (2) AT achieves mental health benefits superior to LT [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>]. It has been reported that AT can increase self-efficacy, improve mood and self-esteem, relieve stress, and reduce anxiety and depression, helping to increase QoL [<xref rid="B54-jfmk-10-00170" ref-type="bibr">54</xref>,<xref rid="B55-jfmk-10-00170" ref-type="bibr">55</xref>,<xref rid="B56-jfmk-10-00170" ref-type="bibr">56</xref>]. (3) AT results in superior improvements in sleep quality than LT [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>]. Given that sleep disorders negatively affect QoL and cognitive status, their correction could have a positive impact on QoL [<xref rid="B57-jfmk-10-00170" ref-type="bibr">57</xref>,<xref rid="B58-jfmk-10-00170" ref-type="bibr">58</xref>]. (4) AT reduces pain significantly more than LT [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>]. Pain sensitivity is increased in PD due to abnormal temporal summation and impaired central pain processing, with lower pain thresholds [<xref rid="B23-jfmk-10-00170" ref-type="bibr">23</xref>]. However, pain is underestimated, underdiagnosed, and undertreated in PD [<xref rid="B48-jfmk-10-00170" ref-type="bibr">48</xref>]. Hot water immersion has anti-allodynic effects mediated by peripheral opioid, cannabinoid, and adenosine receptors in animal models [<xref rid="B59-jfmk-10-00170" ref-type="bibr">59</xref>]. This makes AT an effective option for pain management in PD by increasing QoL.</p></sec><sec id="sec4dot4-jfmk-10-00170"><title>4.4. Strength and Flexibility</title><p>Strength was assessed by four studies [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]. Three of them found significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) increases over baseline [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], but only two over CG [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>]. Analyzing the trial protocols, the pattern identified above is repeated, with only Ai Chi achieving greater increases in strength than LT [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>]. Ai Chi is not only effective in increasing strength in PD, but it has also been reported to provide benefits in strength in other diseases, such as multiple sclerosis [<xref rid="B60-jfmk-10-00170" ref-type="bibr">60</xref>]. Changes in strength after performing an AT protocol may be due to an increase in resistance to movement produced by water viscosity. This requires a greater involvement of the muscle strength components during exercise [<xref rid="B61-jfmk-10-00170" ref-type="bibr">61</xref>].</p><p>The impact of AT on flexibility was only evaluated by Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], who found significant (<italic toggle="yes">p</italic> &#x0003c; 0.05) increases over LT. This may be attributed to the fact that immersion in warm water increases the extensibility of collagen tissue and inhibits stretch reflex excitability, improving flexibility and relieving muscle stiffness [<xref rid="B23-jfmk-10-00170" ref-type="bibr">23</xref>].</p></sec><sec id="sec4dot5-jfmk-10-00170"><title>4.5. Practical Applications</title><p>In order to unify the wide variety of AT protocols designed for PD patients, an evidence-based AT protocol from the 13 trials included in this review is presented in <xref rid="jfmk-10-00170-f004" ref-type="fig">Figure 4</xref>.</p></sec><sec id="sec4dot6-jfmk-10-00170"><title>4.6. Reflections on the Role of Aquatic and Land-Based Physical Exercise in Parkinson&#x02019;s Disease</title><p>Strong clinical evidence has shown a positive correlation between physical exercise and the amelioration of symptoms and side effects of Parkinson&#x02019;s disease. In this context, the question arises as to which approach, aquatic or land-based, may be of most benefit to Parkinson&#x02019;s sufferers. The underlying molecular mechanisms may shed some light on the results reported and guide sports therapies in this regard.</p><p>Irrespective of whether it is aquatic or land-based, physical exercise has shown cognitive improvements in patients with neurodegenerative diseases. Most cognitive benefits associated with exercise have been related to the production of growth factors at local and systemic levels within the hippocampus [<xref rid="B62-jfmk-10-00170" ref-type="bibr">62</xref>]. Brain-derived neurotrophic factor (BDNF), which is involved in the expansion of neural networks and cognitive&#x02013;behavioral functions, plays a key role. Notably, a decrease in BNDF has been characterized in the pathological picture of Parkinson&#x02019;s disease, and the increase in this neurotrophin is, in itself, a potential therapy for the condition [<xref rid="B62-jfmk-10-00170" ref-type="bibr">62</xref>]. Szuhany et al. [<xref rid="B63-jfmk-10-00170" ref-type="bibr">63</xref>] review in a meta-analysis of 14 studies how physical exercise leads to a significant increase in BNDF levels. At the brain level, despite the multitude of studies documenting this issue, it is not known how exercise stimulates BDNF production. However, the hemodynamic hypothesis suggests that the elevation of cerebral blood flow by exercise increases the activity of tissue plasminogen activator (tPA), which is responsible for cleaving proBNDF and producing mature BNDF [<xref rid="B64-jfmk-10-00170" ref-type="bibr">64</xref>].</p><p>Wrann et al. [<xref rid="B65-jfmk-10-00170" ref-type="bibr">65</xref>] demonstrated through their research that FNDC5, an exercise-induced muscle protein initially secreted as irisin, correlates with BNDF expression. FNDC5 is regulated by PGC-1&#x003b1; and has been shown to increase under conditions of hippocampal endurance exercise. The increased expression of FNDC5 in primary cortical neurons results in the upregulation of BNDF expression [<xref rid="B65-jfmk-10-00170" ref-type="bibr">65</xref>]. Water exercise leads to an increase in BNDF and, consequently, cognitive function [<xref rid="B66-jfmk-10-00170" ref-type="bibr">66</xref>,<xref rid="B67-jfmk-10-00170" ref-type="bibr">67</xref>]. Although an increase in BNDF is also found in floor exercises, we suggest that the properties of water may help to achieve higher levels of BNDF, not necessarily due to the type of exercise, but rather because it allows more effort to be exerted without feeling fatigued. This leads to increased performance, which could result in higher levels of BNDF.</p><p>An additional beneficial effect of exercise would be on AMP-activated protein kinase (AMPK) activity in skeletal muscle. This has a positive impact on several brain processes, including improved learning and memory abilities, increased neurogenesis, and regulation of genes associated with mitochondrial function in the hippocampus [<xref rid="B68-jfmk-10-00170" ref-type="bibr">68</xref>]. Aquatic exercise programs reduce chronic low-grade inflammation by decreasing pro-inflammatory markers like tumor necrosis factor &#x003b1; (TNF-&#x003b1;) and increasing anti-inflammatory cytokines such as interleukin 10 (IL-10). This anti-inflammatory response may indirectly enhance pathways like AMPK [<xref rid="B68-jfmk-10-00170" ref-type="bibr">68</xref>]. The hydrostatic pressure of water may improve circulation and lymphatic drainage, enhancing the systemic anti-inflammatory response. Additionally, the cooling effect of water reduces exercise-induced inflammation, further promoting cytokine balance [<xref rid="B69-jfmk-10-00170" ref-type="bibr">69</xref>].</p><p>Physical activity has also been shown to increase circulating levels of insulin-like growth factor 1 (IGF-1). This hormone seems to contribute to the alleviation of Parkinson&#x02019;s symptomatology by increasing hippocampal cell supersurvival capacity and being protective against brain injury [<xref rid="B66-jfmk-10-00170" ref-type="bibr">66</xref>]. It also has the ability to cross the BBB and induce BDNF synthesis in response to exercise [<xref rid="B66-jfmk-10-00170" ref-type="bibr">66</xref>]. Studies comparing aquatic and non-aquatic exercises found that IGF-1 levels increased significantly in both modalities. However, Aquatic exercise also stimulates vascular endothelial growth factor (VEGF), which works synergistically with IGF-1 to enhance vascularization and cognitive function [<xref rid="B66-jfmk-10-00170" ref-type="bibr">66</xref>]. This dual effect may be less pronounced in non-aquatic settings due to differences in exercise dynamics. Also, the buoyancy of water reduces joint stress, allowing participants to engage in higher-intensity movements safely, which may enhance the release of growth factors like IGF-1 compared to LT.</p><p>It is, therefore, suggested that aquatic exercises may provide unique physiological benefits due to the properties of water (buoyancy, resistance, hydrostatic pressure) that favor and enhance the exercise-associated synthesis of key molecules in cognitive enhancement, neuroprotection, and reduction in inflammation.</p></sec><sec id="sec4dot7-jfmk-10-00170"><title>4.7. Future Lines</title><p>During the course of this systematic review, a number of knowledge gaps have been identified and need to be addressed. Firstly, future research should clarify the effectiveness of AT alone on freezing of gait, a symptom that significantly affects PD patients&#x02019; mobility. Also, no study has evaluated the effectiveness of AT on transfers nor the effect of Ai Chi on falls. On the other hand, the effect of AT on strength should be further studied, as only four studies evaluated it, leaving a considerable gap in the understanding of how AT may influence this parameter. Similarly, flexibility and sleep quality were assessed by only one trial, indicating an urgent need for further research.</p></sec><sec id="sec4dot8-jfmk-10-00170"><title>4.8. Limitations and Strengths</title><p>The authors of this review acknowledge some limitations. First, the number of studies that met the selection criteria was limited. However, PRISMA guidelines [<xref rid="B27-jfmk-10-00170" ref-type="bibr">27</xref>] were followed, six relevant databases were searched, and the grey literature was included. In addition, to ensure the methodological quality of the included studies, the CASPe scale [<xref rid="B29-jfmk-10-00170" ref-type="bibr">29</xref>] and the Cochrane bias assessment tool [<xref rid="B30-jfmk-10-00170" ref-type="bibr">30</xref>] were used. Due to the type of intervention, it was not possible for the therapists and participants to remain blinded. However, in nine trials [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>,<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>,<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>,<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>,<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>,<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>,<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>,<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>,<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], the assessors remained blinded, ensuring the absence of bias in this regard. On the other hand, there is great heterogeneity in the parameters assessed and the assessment tool used, which impedes the development of a meta-analysis. In addition, there is significant methodological heterogeneity among the studies, particularly in the AT protocols applied (e.g., type of exercises, session duration, frequency, water temperature), which limits the ability to compare results across interventions and draw generalizable conclusions. Finally, this systematic review was registered in PROSPERO (CRD42024528310) to guarantee its originality.</p></sec></sec><sec sec-type="conclusions" id="sec5-jfmk-10-00170"><title>5. Conclusions</title><p>The efficacy of AT compared to LT for improving balance, gait, and strength in adult PDs appears to be limited. However, preliminary scientific evidence suggests that AT may be particularly superior to LT for improving quality of life, mental health, pain, flexibility, and sleep quality. Ai chi appears to be the most effective therapeutic exercise modality. It has been observed that the practice of supportive therapy does not provide additional benefits when LT is already being performed. No adverse events related to AT have been reported, supporting the fact that AT is a safe treatment strategy. In addition, AT may offer unique physiological advantages, including potential effects on cognitive enhancement, neuroprotection, and inflammation reduction, factors particularly relevant in neurodegenerative diseases. Finally, AT appears to offer benefits in certain outcomes compared to LT, although further studies are needed on biomarkers such as strength and gait, the impact of AT intensity on short- and long-term efficacy, and adherence strategies to aquatic therapy. Moreover, standardizing intervention protocols is essential to improve comparability across studies and to facilitate more robust conclusions in future research.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank the Department of Education of the Junta de Castilla&#x02013;Le&#x000f3;n for funding this study. Also, the authors want to thank the Neurobiology Research Group, Faculty of Medicine of the University of Valladolid, for their collaboration.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, G.S., M.F.-G. and D.F.-L.; data curation, G.S.; formal analysis, G.S. and D.F.-L.; funding acquisition, D.F.-L. and B.G.G.; investigation, G.S. and D.F.-L.; methodology, G.S., D.F.-L. and M.F.-G.; project administration, D.F.-L.; resources, D.F.-L.; software, D.F.-L.; supervision, M.F.-G. and D.F.-L.; validation, M.F.-G., &#x000c1;.M., E.G.-A., B.G.G. and D.F.-L.; visualization, M.F.-G., &#x000c1;.M., E.G.-A., B.G.G. and D.F.-L.; writing&#x02014;original draft, G.S. and D.F.-L.; writing&#x02014;review and editing, M.F.-G., &#x000c1;.M., E.G.-A. and B.G.G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>All authors declared that there are no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">AMPK</td><td align="left" valign="middle" rowspan="1" colspan="1">AMP-activated protein kinase </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AT</td><td align="left" valign="middle" rowspan="1" colspan="1">Aquatic-based therapeutic exercise </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BDNF</td><td align="left" valign="middle" rowspan="1" colspan="1">Brain-derived neurotrophic factor </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CASPe</td><td align="left" valign="middle" rowspan="1" colspan="1">Critical Appraisal Skills Program in Spanish</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CG</td><td align="left" valign="middle" rowspan="1" colspan="1">Control group </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FNDCS </td><td align="left" valign="middle" rowspan="1" colspan="1">Fibronectin type III domain-containing proteins </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IG</td><td align="left" valign="middle" rowspan="1" colspan="1">Intervention group</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IGF-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Insulin-like growth factor 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-10</td><td align="left" valign="middle" rowspan="1" colspan="1">Interleukin 10</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LT</td><td align="left" valign="middle" rowspan="1" colspan="1">Land-based therapeutic exercise </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MeSH</td><td align="left" valign="middle" rowspan="1" colspan="1">Medical Subject Headings </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PD</td><td align="left" valign="middle" rowspan="1" colspan="1">Parkinson&#x02019;s Disease </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PEDro</td><td align="left" valign="middle" rowspan="1" colspan="1">Physiotherapy Evidence Database </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">QoL</td><td align="left" valign="middle" rowspan="1" colspan="1">Quality of life </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNF&#x003b1;</td><td align="left" valign="middle" rowspan="1" colspan="1">Tumor necrosis factor-alpha </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PGC-1&#x003b1;</td><td align="left" valign="middle" rowspan="1" colspan="1">Peroxime proliferator-activated receptor gamma coactivator 1-alpha </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PRISMA</td><td align="left" valign="middle" rowspan="1" colspan="1">Preferred Reporting Items for Systematic Reviews and Meta-analyses </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tpa</td><td align="left" valign="middle" rowspan="1" colspan="1">Tissue plasminogen activator</td></tr></tbody></array></p></glossary><app-group><app id="app1-jfmk-10-00170"><title>Appendix A. Checklist PRISMA 2020 [<xref rid="B27-jfmk-10-00170" ref-type="bibr">27</xref>]</title><array><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Section and Topic</bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Item</bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Checklist Item</bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Location Where Item Is Reported</bold>
</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Title </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Title </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Identify the report as a systematic review.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Abstract </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abstract </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">See the PRISMA 2020 for Abstracts checklist.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;2</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Introduction </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rationale </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe the rationale for this review in the context of existing knowledge.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Objectives </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Provide an explicit statement of the objective(s) or question(s) the review addresses.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Methods </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eligibility criteria </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specify the inclusion and exclusion criteria for this review and how studies were grouped for the syntheses.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Information sources </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specify all databases, registers, websites, organizations, reference lists, and other sources searched or consulted to identify studies. Specify the date when each source was last searched or consulted.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Search strategy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Present the full search strategies for all databases, registers, and websites, including any filters and limits used.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 and 29</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Selection process</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specify the methods used to decide whether a study met the inclusion criteria of this review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and, if applicable, details of automation tools used in the process.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Data collection process </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used in the process.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Data items </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g., for all measures, time points, analyses), and if not, the methods used to decide which results to collect.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">List and define all other variables for which data were sought (e.g., participant and intervention characteristics, funding sources). Describe any assumptions made about any missing or unclear information.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study risk of bias assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specify the methods used to assess the risk of bias in the included studies, including details of the tool(s) used, how many reviewers assessed each study, whether they worked independently, and, if applicable, details of automation tools used in this process.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effect measures </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specify for each outcome the effect measure(s) (e.g., risk ratio, mean difference) used in the synthesis or presentation of results.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Synthesis methods</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe the processes used to decide which studies were eligible for each synthesis (e.g., tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe any methods required to prepare the data for presentation or synthesis, such as handling missing summary statistics or data conversions.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13c</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe any methods used to tabulate or visually display results of individual studies and syntheses.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13d</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was performed, describe the model(s) and method(s) to identify the presence and extent of statistical heterogeneity and software package(s) used.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13e</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe any methods used to explore possible causes of heterogeneity among study results (e.g., subgroup analysis, meta-regression).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13f</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe any sensitivity analyses conducted to assess robustness of the synthesized results.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reporting bias assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Certainty assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Results </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Study selection </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in this review, ideally using a flow diagram.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x02013;5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cite studies that might appear to meet the inclusion criteria but which were excluded, and explain why they were excluded.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x02013;5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study characteristics </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cite each included study and present its characteristics.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 and 10&#x02013;18</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Risk of bias in studies </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Present assessments of risk of bias for each included study.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6&#x02013;8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Results of individual studies </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g., confidence/credible interval), ideally using structured tables or plots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8&#x02013;16 and 19</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Results of syntheses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For each synthesis, briefly summarize the characteristics and risk of bias among contributing studies.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Present results of all statistical syntheses conducted. If meta-analysis was performed, present for each the summary estimate and its precision (e.g., confidence/credible interval) and measures of statistical heterogeneity. If comparing groups, describe the direction of the effect.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20c</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Present results of all investigations of possible causes of heterogeneity among study results.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20d</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Present results of all sensitivity analyses conducted to assess the robustness of the synthesized results.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reporting biases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Present assessments of risk of bias due to missing results (arising from reporting biases) for each synthesis assessed.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Certainty of evidence </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Present assessments of certainty (or confidence) in the body of evidence for each outcome assessed.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Discussion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Discussion </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Provide a general interpretation of the results in the context of other evidence.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19&#x02013;23</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discuss any limitations of the evidence included in this review.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23c</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discuss any limitations of the review processes used.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23d</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discuss implications of the results for practice, policy, and future research.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21&#x02013;23</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Other information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Registration and protocol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24a</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Provide registration information for this review, including register name and registration number, or state that this review was not registered.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indicate where the review protocol can be accessed, or state that a protocol was not prepared.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24c</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe and explain any amendments to information provided at registration or in the protocol.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Support</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Describe sources of financial or non-financial support for this review and the role of the funders or sponsors in this review.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Competing interests</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Declare any competing interests of review authors.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Availability of data, code, and other materials</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Report which of the following are publicly available and where they can be found: template data collection forms; data extracted from included studies; data used for all analyses; analytic code; any other materials used in this review.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr></tbody></array></app><app id="app2-jfmk-10-00170"><title>Appendix B. Search Strategy Employed in Databases</title><array><tbody><tr><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Database</bold>
</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Search Strategy</bold>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medline/Pubmed</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Parkinson Disease (MeSH) OR Parkinson OR Parkinson&#x02019;s Disease) AND (Aquatic Therapy (MeSH) OR Aquatic Exercise Therapy OR Water Exercise Therapy OR Ai Chi Therapy)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scopus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(TITLE-ABS-KEY (&#x0201c;parkinson disease&#x0201d; OR Parkinson OR &#x0201c;Parkinson&#x02019;s Disease&#x0201d;) AND TITLE-ABS-KEY (&#x0201c;Aquatic Therapy&#x0201d; OR &#x0201c;Aquatic Exercise Therapy&#x0201d; OR &#x0201c;Water Exercise Therapy&#x0201d; OR &#x0201c;ai chi therapy&#x0201d;))</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Web of Science</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parkinson Disease (topic) AND Aquatic Therapy (Topic)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEDro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parkinson disease AND hydrotherapy, balneotherapy</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CINAHL</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Parkinson disease OR Parkinson OR Parkinson&#x02019;s Disease) AND (Aquatic therapy OR Aquatic Exercise Therapy OR Water Exercise Therapy OR ai chi therapy)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cochrane</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parkinson Disease AND Aquatic Therapy</td></tr></tbody></array></app></app-group><ref-list><title>References</title><ref id="B1-jfmk-10-00170"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cabreira</surname><given-names>V.</given-names></name>
<name><surname>Massano</surname><given-names>J.</given-names></name>
</person-group><article-title>Parkinson&#x02019;s Disease: Clinical Review and Update</article-title><source>Acta Med. Port.</source><year>2019</year><volume>32</volume><fpage>661</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.20344/amp.11978</pub-id><pub-id pub-id-type="pmid">31625879</pub-id>
</element-citation></ref><ref id="B2-jfmk-10-00170"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayes</surname><given-names>M.T.</given-names></name>
</person-group><article-title>Parkinson&#x02019;s Disease and Parkinsonism</article-title><source>Am. J. Med.</source><year>2019</year><volume>132</volume><fpage>802</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2019.03.001</pub-id><pub-id pub-id-type="pmid">30890425</pub-id>
</element-citation></ref><ref id="B3-jfmk-10-00170"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Warnecke</surname><given-names>T.</given-names></name>
<name><surname>Lummer</surname><given-names>C.</given-names></name>
<name><surname>Wilhelm</surname><given-names>R.</given-names></name>
<name><surname>Claus</surname><given-names>I.</given-names></name>
<name><surname>L&#x000fc;ttje</surname><given-names>D.</given-names></name>
</person-group><article-title>Parkinson&#x02019;s disease</article-title><source>Inn. Med.</source><year>2023</year><volume>64</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1007/s00108-022-01444-3</pub-id></element-citation></ref><ref id="B4-jfmk-10-00170"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reich</surname><given-names>S.</given-names></name>
<name><surname>Savitt</surname><given-names>J.</given-names></name>
</person-group><article-title>Parkinson&#x02019;s Disease</article-title><source>Med. Clin. N. Am.</source><year>2019</year><volume>103</volume><fpage>337</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/j.mcna.2018.10.014</pub-id><pub-id pub-id-type="pmid">30704685</pub-id>
</element-citation></ref><ref id="B5-jfmk-10-00170"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cerri</surname><given-names>S.</given-names></name>
<name><surname>Mus</surname><given-names>L.</given-names></name>
<name><surname>Blandini</surname><given-names>F.</given-names></name>
</person-group><article-title>Parkinson&#x02019;s Disease in Women and Men: What&#x02019;s the Difference?</article-title><source>J. Park. Dis.</source><year>2019</year><volume>9</volume><fpage>501</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.3233/JPD-191683</pub-id></element-citation></ref><ref id="B6-jfmk-10-00170"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ascherio</surname><given-names>A.</given-names></name>
<name><surname>Schwarzschild</surname><given-names>M.</given-names></name>
</person-group><article-title>The epidemiology of Parkinson&#x02019;s disease: Risk factors and prevention</article-title><source>Lancet Neurol.</source><year>2016</year><volume>15</volume><fpage>1257</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(16)30230-7</pub-id><pub-id pub-id-type="pmid">27751556</pub-id>
</element-citation></ref><ref id="B7-jfmk-10-00170"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dorsey</surname><given-names>E.</given-names></name>
<name><surname>Sherer</surname><given-names>T.</given-names></name>
<name><surname>Okun</surname><given-names>M.</given-names></name>
<name><surname>Bloem</surname><given-names>B.</given-names></name>
</person-group><article-title>The Emerging Evidence of the Parkinson Pandemic</article-title><source>J. Park. Dis.</source><year>2018</year><volume>8</volume><fpage>S3</fpage><lpage>S8</lpage><pub-id pub-id-type="doi">10.3233/JPD-181474</pub-id></element-citation></ref><ref id="B8-jfmk-10-00170"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allen</surname><given-names>L.</given-names></name>
</person-group><article-title>Are we facing a noncommunicable disease pandemic?</article-title><source>J. Epidemiol. Glob. Heal.</source><year>2017</year><volume>7</volume><fpage>5</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jegh.2016.11.001</pub-id></element-citation></ref><ref id="B9-jfmk-10-00170"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bellou</surname><given-names>V.</given-names></name>
<name><surname>Belbasis</surname><given-names>L.</given-names></name>
<name><surname>Tzoulaki</surname><given-names>I.</given-names></name>
<name><surname>Evangelou</surname><given-names>E.</given-names></name>
<name><surname>Ioannidis</surname><given-names>J.</given-names></name>
</person-group><article-title>Environmental risk factors and Parkinson&#x02019;s disease: An umbrella review of meta-analyses</article-title><source>Park. Relat. Disord.</source><year>2016</year><volume>23</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2015.12.008</pub-id></element-citation></ref><ref id="B10-jfmk-10-00170"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hvingelby</surname><given-names>V.</given-names></name>
<name><surname>Glud</surname><given-names>A.</given-names></name>
<name><surname>Sorensen</surname><given-names>J.</given-names></name>
<name><surname>Tai</surname><given-names>Y.</given-names></name>
<name><surname>Andersen</surname><given-names>A.</given-names></name>
<name><surname>Johnsen</surname><given-names>E.</given-names></name>
<name><surname>Moro</surname><given-names>E.</given-names></name>
<name><surname>Pavese</surname><given-names>N.</given-names></name>
</person-group><article-title>Interventions to improve gait in Parkinson&#x02019;s disease: A systematic review of randomized controlled trials and network meta-analysis</article-title><source>J. Neurol.</source><year>2022</year><volume>269</volume><fpage>4068</fpage><lpage>4079</lpage><pub-id pub-id-type="doi">10.1007/s00415-022-11091-1</pub-id><pub-id pub-id-type="pmid">35378605</pub-id>
</element-citation></ref><ref id="B11-jfmk-10-00170"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hao</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>P.</given-names></name>
</person-group><article-title>Effects of Ten Different Exercise Intervention on Motor Function in Parkinson&#x02019;s Disease Patients: A Network Meta-Analysis of Randommized Controlled Trials</article-title><source>Brain Sci.</source><year>2022</year><volume>12</volume><elocation-id>698</elocation-id><pub-id pub-id-type="doi">10.3390/brainsci12060698</pub-id><pub-id pub-id-type="pmid">35741584</pub-id>
</element-citation></ref><ref id="B12-jfmk-10-00170"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>D.</given-names></name>
<name><surname>Ba</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
</person-group><article-title>Exercise sustains motor function in Parkinson&#x02019;s Disease: Evidence from 109 randomized controlled trials on over 4600 patients</article-title><source>Front. Aging Neurosci.</source><year>2023</year><volume>15</volume><elocation-id>1071803</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2023.1071803</pub-id><pub-id pub-id-type="pmid">36865410</pub-id>
</element-citation></ref><ref id="B13-jfmk-10-00170"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deepa</surname><given-names>S.</given-names></name>
<name><surname>Kumaresan</surname><given-names>A.</given-names></name>
<name><surname>Suganthirababu</surname><given-names>P.</given-names></name>
<name><surname>Vishnuram</surname><given-names>S.</given-names></name>
<name><surname>Srinivasan</surname><given-names>V.</given-names></name>
</person-group><article-title>A need to reconsider the rehabilitation protocol in patients with idiopatic Parkinson&#x02019;s disease: Review analysis</article-title><source>Biomedicine</source><year>2022</year><volume>42</volume><fpage>657</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.51248/.v42i4.375</pub-id></element-citation></ref><ref id="B14-jfmk-10-00170"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El Hayek</surname><given-names>M.</given-names></name>
<name><surname>Lobo Jofili</surname><given-names>J.</given-names></name>
<name><surname>LeLaurin</surname><given-names>J.</given-names></name>
<name><surname>Gregory</surname><given-names>M.</given-names></name>
<name><surname>Abi Nehme</surname><given-names>A.</given-names></name>
<name><surname>McCall-Junkin</surname><given-names>P.</given-names></name>
<name><surname>KLK</surname><given-names>A.</given-names></name>
<name><surname>Okun</surname><given-names>M.</given-names></name>
<name><surname>Salloum</surname><given-names>R.</given-names></name>
</person-group><article-title>Type, Timing, Frequency, and Durability of Outcome of Physical Therapy for Parkinson Disease: A systematic Review and Meta-Analysis</article-title><source>JAMA Netw. Open</source><year>2023</year><volume>6</volume><fpage>e2324860</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.24860</pub-id><pub-id pub-id-type="pmid">37477916</pub-id>
</element-citation></ref><ref id="B15-jfmk-10-00170"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mooventhan</surname><given-names>A.</given-names></name>
<name><surname>Nivethitha</surname><given-names>L.</given-names></name>
</person-group><article-title>Scientific evidence-based effects of hydrotherapy on varius systems of the body</article-title><source>N. Am. J. Med. Sci.</source><year>2014</year><volume>6</volume><fpage>199</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.4103/1947-2714.132935</pub-id><pub-id pub-id-type="pmid">24926444</pub-id>
</element-citation></ref><ref id="B16-jfmk-10-00170"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>BE</surname><given-names>B.</given-names></name>
</person-group><article-title>Aquatic Therapy: Scientific foundations and clinical rehabilitation applications</article-title><source>PM R</source><year>2009</year><volume>1</volume><fpage>859</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1016/j.pmrj.2009.05.017</pub-id><pub-id pub-id-type="pmid">19769921</pub-id>
</element-citation></ref><ref id="B17-jfmk-10-00170"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Coraci</surname><given-names>D.</given-names></name>
<name><surname>Tognolo</surname><given-names>L.</given-names></name>
<name><surname>Maccarone</surname><given-names>M.C.</given-names></name>
<name><surname>Santilli</surname><given-names>G.</given-names></name>
<name><surname>Ronconi</surname><given-names>G.</given-names></name>
<name><surname>Masiero</surname><given-names>S.</given-names></name>
</person-group><article-title>Water-Based Rehabilitation in the Elderly: Data Science Approach to Support the Conduction of a Scoping Review</article-title><source>Appl. Sci.</source><year>2022</year><volume>12</volume><elocation-id>8999</elocation-id><pub-id pub-id-type="doi">10.3390/app12188999</pub-id></element-citation></ref><ref id="B18-jfmk-10-00170"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Ruan</surname><given-names>Y.</given-names></name>
<name><surname>Dai</surname><given-names>S.</given-names></name>
</person-group><article-title>Efficacy of aquatic exercise in chronic musculoskeletal disorders: A systematic review and meta-analysis of randomized controlled trials</article-title><source>J. Orthop. Surg. Res.</source><year>2023</year><volume>18</volume><fpage>942</fpage><pub-id pub-id-type="doi">10.1186/s13018-023-04417-w</pub-id><pub-id pub-id-type="pmid">38066577</pub-id>
</element-citation></ref><ref id="B19-jfmk-10-00170"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fa&#x000ed;l</surname><given-names>L.</given-names></name>
<name><surname>Marinho</surname><given-names>D.</given-names></name>
<name><surname>Marques</surname><given-names>E.</given-names></name>
<name><surname>Costa</surname><given-names>M.</given-names></name>
<name><surname>Santos</surname><given-names>C.</given-names></name>
<name><surname>Marques</surname><given-names>M.</given-names></name>
<name><surname>Izquierdo</surname><given-names>M.</given-names></name>
<name><surname>Neiva</surname><given-names>H.</given-names></name>
</person-group><article-title>Benefits of Aquatic exercise in adults with and without chronic disease-A systematic review with meta-analysis</article-title><source>Scand. J. Med. Sci. Sport.</source><year>2022</year><volume>32</volume><fpage>465</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1111/sms.14112</pub-id></element-citation></ref><ref id="B20-jfmk-10-00170"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cugusi</surname><given-names>L.</given-names></name>
<name><surname>Manca</surname><given-names>A.</given-names></name>
<name><surname>Bergamin</surname><given-names>M.</given-names></name>
<name><surname>Di Blasio</surname><given-names>A.</given-names></name>
<name><surname>Monticone</surname><given-names>M.</given-names></name>
<name><surname>Deriu</surname><given-names>F.</given-names></name>
<name><surname>Mercuro</surname><given-names>G.</given-names></name>
</person-group><article-title>Aquatic Exercise improves motor impairments in people with Parkinson&#x02019;s disease, with similar or greater benefits than land-based exercise: A systematic review</article-title><source>J. Physiother.</source><year>2019</year><volume>65</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.jphys.2019.02.003</pub-id><pub-id pub-id-type="pmid">30904467</pub-id>
</element-citation></ref><ref id="B21-jfmk-10-00170"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Methajarunon</surname><given-names>P.</given-names></name>
<name><surname>Eitivipart</surname><given-names>C.</given-names></name>
<name><surname>Diver</surname><given-names>C.</given-names></name>
<name><surname>Foongchomcheavy</surname><given-names>A.</given-names></name>
</person-group><article-title>systematic review of published studies on aquatic exercise for balance in patientes with multiple sclerosis, Parkinson&#x02019;s disease, and hemiplegia</article-title><source>Foongchomcheavy</source><year>2016</year><volume>35</volume><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.hkpj.2016.03.002</pub-id></element-citation></ref><ref id="B22-jfmk-10-00170"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Plecash</surname><given-names>A.</given-names></name>
<name><surname>Leavitt</surname><given-names>B.</given-names></name>
</person-group><article-title>Aquatherapy for neurodegenerative disorders</article-title><source>J. Huntingtons. Dis.</source><year>2014</year><volume>3</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3233/JHD-140010</pub-id><pub-id pub-id-type="pmid">25062761</pub-id>
</element-citation></ref><ref id="B23-jfmk-10-00170"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dai</surname><given-names>S.</given-names></name>
<name><surname>Yuan</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Wen</surname><given-names>S.</given-names></name>
</person-group><article-title>Effects of aquatic exercise on the improvement of lower-extremity motor function and quality of life in patients with Parkinson&#x02019;s disease: A meta-analysis</article-title><source>Front. Physiol.</source><year>2023</year><volume>14</volume><elocation-id>1066718</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2023.1066718</pub-id><pub-id pub-id-type="pmid">36818451</pub-id>
</element-citation></ref><ref id="B24-jfmk-10-00170"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moritz</surname><given-names>T.</given-names></name>
<name><surname>Snowdon</surname><given-names>D.</given-names></name>
<name><surname>Peiris</surname><given-names>C.</given-names></name>
</person-group><article-title>combining aquatic physiotherapy with usual care physiotherapy for people with neurological conditions: A systematic review</article-title><source>Physiother. Res. Int.</source><year>2020</year><volume>25</volume><fpage>e1813</fpage><pub-id pub-id-type="doi">10.1002/pri.1813</pub-id><pub-id pub-id-type="pmid">31594035</pub-id>
</element-citation></ref><ref id="B25-jfmk-10-00170"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terrens</surname><given-names>A.</given-names></name>
<name><surname>Soh</surname><given-names>S.</given-names></name>
<name><surname>Morgan</surname><given-names>P.</given-names></name>
</person-group><article-title>The efficacy and feasibility of aquatic physiotherapy for people with Parkinson&#x02019;s disease: A systematic review</article-title><source>Disabil. Rehabil.</source><year>2018</year><volume>40</volume><fpage>2847</fpage><lpage>2856</lpage><pub-id pub-id-type="doi">10.1080/09638288.2017.1362710</pub-id><pub-id pub-id-type="pmid">28793808</pub-id>
</element-citation></ref><ref id="B26-jfmk-10-00170"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pritchard</surname><given-names>M.</given-names></name>
<name><surname>Laster</surname><given-names>J.</given-names></name>
<name><surname>Rogers</surname><given-names>L.</given-names></name>
<name><surname>Schultz</surname><given-names>A.</given-names></name>
<name><surname>Babl</surname><given-names>R.</given-names></name>
</person-group><article-title>The Effects of Aquatic Therapy on Gait, Balance, and Quality of Life in Patients With Parkinson&#x02019;s Disease</article-title><source>J. Aquat. Phys. Ther.</source><year>2019</year><volume>27</volume><fpage>10</fpage><lpage>24</lpage></element-citation></ref><ref id="B27-jfmk-10-00170"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id>
</element-citation></ref><ref id="B28-jfmk-10-00170"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>da Costa Santos</surname><given-names>C.M.</given-names></name>
<name><surname>de Mattos Pimenta</surname><given-names>C.A.</given-names></name>
<name><surname>Nobre</surname><given-names>M.R.C.</given-names></name>
</person-group><article-title>The PICO Strategy for the Research Question Construction and Evidence Search</article-title><source>Rev. Lat. Am. Enfermagem</source><year>2007</year><volume>15</volume><fpage>508</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1590/S0104-11692007000300023</pub-id><pub-id pub-id-type="pmid">17653438</pub-id>
</element-citation></ref><ref id="B29-jfmk-10-00170"><label>29.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Cabello L&#x000f3;pez</surname><given-names>J.</given-names></name>
</person-group><source>Lectura Cr&#x000ed;tica de la Evidencia Cl&#x000ed;nica</source><edition>2nd ed.</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Barcelona, Spain</publisher-loc><year>2021</year><isbn>9788491138839</isbn></element-citation></ref><ref id="B30-jfmk-10-00170"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>J.P.T.</given-names></name>
<name><surname>Altman</surname><given-names>D.G.</given-names></name>
<name><surname>G&#x000f8;tzsche</surname><given-names>P.C.</given-names></name>
<name><surname>J&#x000fc;ni</surname><given-names>P.</given-names></name>
<name><surname>Moher</surname><given-names>D.</given-names></name>
<name><surname>Oxman</surname><given-names>A.D.</given-names></name>
<name><surname>Savovi&#x00107;</surname><given-names>J.</given-names></name>
<name><surname>Schulz</surname><given-names>K.F.</given-names></name>
<name><surname>Weeks</surname><given-names>L.</given-names></name>
<name><surname>Sterne</surname><given-names>J.A.C.</given-names></name>
</person-group><article-title>The Cochrane Collaboration&#x02019;s tool for assessing risk of bias in randomised trials</article-title><source>BMJ</source><year>2011</year><volume>343</volume><fpage>d5928</fpage><pub-id pub-id-type="doi">10.1136/bmj.d5928</pub-id><pub-id pub-id-type="pmid">22008217</pub-id>
</element-citation></ref><ref id="B31-jfmk-10-00170"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clerici</surname><given-names>I.</given-names></name>
<name><surname>Maestri</surname><given-names>R.</given-names></name>
<name><surname>Bonetti</surname><given-names>F.</given-names></name>
<name><surname>Ortelli</surname><given-names>P.</given-names></name>
<name><surname>Volpe</surname><given-names>D.</given-names></name>
<name><surname>Ferrazzoli</surname><given-names>D.</given-names></name>
<name><surname>Frazzitta</surname><given-names>G.</given-names></name>
</person-group><article-title>Land Plus Aquatic Therapy Versus Land-Based Rehabilitation Alone for the Treatment of Freezing of Gait in Parkinson Disease: A Randomized Controlled Trial</article-title><source>Phys. Ther.</source><year>2019</year><volume>99</volume><fpage>591</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1093/ptj/pzz003</pub-id><pub-id pub-id-type="pmid">30657995</pub-id>
</element-citation></ref><ref id="B32-jfmk-10-00170"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kurt</surname><given-names>E.</given-names></name>
<name><surname>B&#x000fc;y&#x000fc;kturan</surname><given-names>B.</given-names></name>
<name><surname>B&#x000fc;y&#x000fc;kturan</surname><given-names>&#x000d6;.</given-names></name>
<name><surname>Erdem</surname><given-names>H.</given-names></name>
<name><surname>Tuncay</surname><given-names>F.</given-names></name>
</person-group><article-title>Effects of Ai Chi on balance, quality of life, functional mobility, and motor impairment in patients with Parkinson&#x02019;s disease</article-title><source>Disabil. Rehabil.</source><year>2018</year><volume>40</volume><fpage>791</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1080/09638288.2016.1276972</pub-id><pub-id pub-id-type="pmid">28084851</pub-id>
</element-citation></ref><ref id="B33-jfmk-10-00170"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-de la Cruz</surname><given-names>S.</given-names></name>
</person-group><article-title>Mental health in Parkinson&#x02019;s disease after receiving aquatic therapy: A clinical trial</article-title><source>Acta Neurol. Belg.</source><year>2019</year><volume>119</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/s13760-018-1034-5</pub-id><pub-id pub-id-type="pmid">30413971</pub-id>
</element-citation></ref><ref id="B34-jfmk-10-00170"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-de la Cruz</surname><given-names>S.</given-names></name>
</person-group><article-title>A bicentric controlled study on the effects of aquatic Ai Chi in Parkinson disease</article-title><source>Complement. Ther. Med.</source><year>2018</year><volume>36</volume><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2017.12.001</pub-id><pub-id pub-id-type="pmid">29458923</pub-id>
</element-citation></ref><ref id="B35-jfmk-10-00170"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez de la Cruz</surname><given-names>S.</given-names></name>
</person-group><article-title>Effectiveness of aquatic therapy for the control of pain and increased functionality in people with Parkinson&#x02019;s disease</article-title><source>Eur. J. phys. Rehabil. Med.</source><year>2017</year><volume>53</volume><fpage>825</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.23736/S1973-9087.17.04647-0</pub-id><pub-id pub-id-type="pmid">28627861</pub-id>
</element-citation></ref><ref id="B36-jfmk-10-00170"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shahmohammadi</surname><given-names>R.</given-names></name>
<name><surname>Sharifi</surname><given-names>G.</given-names></name>
<name><surname>Melvin</surname><given-names>J.</given-names></name>
<name><surname>Sadeghi-Demned</surname><given-names>E.</given-names></name>
</person-group><article-title>A comparison between aquatic and land-based physical exercise on postural sway and quality of life in people with Parkinson&#x02019;s disease: A randomized controlled pilot study</article-title><source>Sport Sci. Health</source><year>2017</year><volume>13</volume><fpage>341</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1007/s11332-017-0363-8</pub-id></element-citation></ref><ref id="B37-jfmk-10-00170"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terrens</surname><given-names>A.</given-names></name>
<name><surname>Soh</surname><given-names>S.</given-names></name>
<name><surname>Morgan</surname><given-names>P.</given-names></name>
</person-group><article-title>The safety and feasibility of a Halliwick style of aquatic physiotherapy for falls and balance dysfunction in people with Parkinson&#x02019;s Disease: A single blind pilot trial</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0236391</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0236391</pub-id><pub-id pub-id-type="pmid">32730325</pub-id>
</element-citation></ref><ref id="B38-jfmk-10-00170"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Volpe</surname><given-names>D.</given-names></name>
<name><surname>Giantin</surname><given-names>M.</given-names></name>
<name><surname>Manuela</surname><given-names>P.</given-names></name>
<name><surname>Filippetto</surname><given-names>C.</given-names></name>
<name><surname>Pelosin</surname><given-names>E.</given-names></name>
<name><surname>Abbruzzese</surname><given-names>G.</given-names></name>
<name><surname>Anttonini</surname><given-names>A.</given-names></name>
</person-group><article-title>Water-based vs. non-water-based physiotherapy for rehabilitation of postural deformities in Parkinson&#x02019;s disease: A randomized controlled pilot study</article-title><source>Clin. Rehabil.</source><year>2017</year><volume>31</volume><fpage>1107</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1177/0269215516664122</pub-id><pub-id pub-id-type="pmid">27512099</pub-id>
</element-citation></ref><ref id="B39-jfmk-10-00170"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Volpe</surname><given-names>D.</given-names></name>
<name><surname>Giatin</surname><given-names>M.</given-names></name>
<name><surname>Giantin</surname><given-names>M.</given-names></name>
<name><surname>Maestri</surname><given-names>R.</given-names></name>
<name><surname>Frazzitta</surname><given-names>G.</given-names></name>
</person-group><article-title>Comparing the effects of hydrotherapy and land-based therapy on balance in patients with Parkinson&#x02019;s disease: A randomized controlled pilot study</article-title><source>Clin. Rehabil.</source><year>2014</year><volume>28</volume><fpage>1210</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1177/0269215514536060</pub-id><pub-id pub-id-type="pmid">24895382</pub-id>
</element-citation></ref><ref id="B40-jfmk-10-00170"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Loureiro</surname><given-names>A.</given-names></name>
<name><surname>Burkot</surname><given-names>J.</given-names></name>
<name><surname>Oliveira</surname><given-names>J.</given-names></name>
<name><surname>Barbosa</surname><given-names>J.</given-names></name>
</person-group><article-title>WATSU therapy for individuals with Parkinson&#x02019;s disease to improve quality of sleep and quality of life: A randomized controlled study</article-title><source>Complement. Ther. Med. Pract.</source><year>2022</year><volume>46</volume><fpage>101523</fpage><pub-id pub-id-type="doi">10.1016/j.ctcp.2021.101523</pub-id></element-citation></ref><ref id="B41-jfmk-10-00170"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nogueira</surname><given-names>A.</given-names></name>
<name><surname>dos Santos</surname><given-names>M.</given-names></name>
<name><surname>Passos-Monteiro</surname><given-names>E.</given-names></name>
<name><surname>Wolffenbuttel</surname><given-names>M.</given-names></name>
<name><surname>Gimenes</surname><given-names>R.</given-names></name>
<name><surname>Zimmermann</surname><given-names>M.</given-names></name>
<name><surname>Janner</surname><given-names>A.</given-names></name>
<name><surname>Palmeiro</surname><given-names>L.</given-names></name>
<name><surname>Gomez</surname><given-names>L.</given-names></name>
<name><surname>Gomes</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>The effects of Brazilian dance, deep-water exercise and nordic walking, pre- and post-12 weeks, on functional-motor and non-motor symptoms in trained PwPD</article-title><source>Arch. Gerontol. Geriatr.</source><year>2024</year><volume>118</volume><fpage>105285</fpage><pub-id pub-id-type="doi">10.1016/j.archger.2023.105285</pub-id><pub-id pub-id-type="pmid">38056105</pub-id>
</element-citation></ref><ref id="B42-jfmk-10-00170"><label>42.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Nowak</surname><given-names>I.</given-names></name>
</person-group><source>The Effect of Land-Based and Aquatic Exercise Interventions in the Management of Parkinson&#x02019;s Disease Patients</source><publisher-name>University of Johannesburg</publisher-name><publisher-loc>Johannesburg, South Africa</publisher-loc><year>2018</year></element-citation></ref><ref id="B43-jfmk-10-00170"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palamara</surname><given-names>G.</given-names></name>
<name><surname>Gotti</surname><given-names>F.</given-names></name>
<name><surname>Maestri</surname><given-names>R.</given-names></name>
<name><surname>Bera</surname><given-names>R.</given-names></name>
<name><surname>Gargantini</surname><given-names>R.</given-names></name>
<name><surname>Bossio</surname><given-names>F.</given-names></name>
<name><surname>Zivi</surname><given-names>I.</given-names></name>
<name><surname>Volpe</surname><given-names>D.</given-names></name>
<name><surname>Ferrazzoli</surname><given-names>D.</given-names></name>
<name><surname>Frazzitta</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Land Plus Aquatic Therapy Versus Land-Based Rehabilitation Alone for the Treatment of Balance Dysfunction in Parkinson Disease: A Randomized Controlled Study With 6-Month Follow-Up</article-title><source>Phys. Ther.</source><year>2017</year><volume>98</volume><fpage>1077</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2017.01.025</pub-id><pub-id pub-id-type="pmid">28254636</pub-id>
</element-citation></ref><ref id="B44-jfmk-10-00170"><label>44.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<name><surname>Association</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Australian Guidelines for Aquatic Physiotherapist Working in and/or Managing Hydrotherapy Pools</article-title><year>2015</year><comment>Available online: <ext-link xlink:href="https://docslib.org/doc/11521132/australian-guidelines-for-aquatic-physiotherapists-working-in-and-or-managing-hydrotherapy-pools" ext-link-type="uri">https://docslib.org/doc/11521132/australian-guidelines-for-aquatic-physiotherapists-working-in-and-or-managing-hydrotherapy-pools</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-02-23">(accessed on 23 February 2025)</date-in-citation></element-citation></ref><ref id="B45-jfmk-10-00170"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Port</surname><given-names>R.</given-names></name>
<name><surname>Rumsby</surname><given-names>M.</given-names></name>
<name><surname>Brown</surname><given-names>G.</given-names></name>
<name><surname>Harrison</surname><given-names>I.</given-names></name>
<name><surname>Amjad</surname><given-names>A.</given-names></name>
<name><surname>Bale</surname><given-names>C.</given-names></name>
</person-group><article-title>People with Parkinson&#x02019;s Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?</article-title><source>J. Park. Dis.</source><year>2021</year><volume>11</volume><fpage>715</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.3233/JPD-202346</pub-id><pub-id pub-id-type="pmid">33459664</pub-id>
</element-citation></ref><ref id="B46-jfmk-10-00170"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Samoudi</surname><given-names>G.</given-names></name>
<name><surname>Jivegard</surname><given-names>M.</given-names></name>
<name><surname>Mulavara</surname><given-names>A.</given-names></name>
<name><surname>Bergquist</surname><given-names>F.</given-names></name>
</person-group><article-title>Effects of Stochastic Vestibular Galvanic Stimulation and LDOPA on Balance and Motor Symptoms in Patients with Parkinson&#x02019;s Disease</article-title><source>Brain Stimul.</source><year>2015</year><volume>8</volume><fpage>474</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.brs.2014.11.019</pub-id><pub-id pub-id-type="pmid">25573070</pub-id>
</element-citation></ref><ref id="B47-jfmk-10-00170"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Huang</surname><given-names>M.</given-names></name>
<name><surname>Liao</surname><given-names>Y.</given-names></name>
<name><surname>Xie</surname><given-names>X.</given-names></name>
<name><surname>Zhu</surname><given-names>P.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Tan</surname><given-names>C.</given-names></name>
</person-group><article-title>Long-term efficacy of hydrotherapy on balance function in patients with Parkinson&#x02019;s disease: A systematic review and meta-analysis</article-title><source>Front. Aging Neurosci.</source><year>2023</year><volume>15</volume><elocation-id>1320240</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2023.1320240</pub-id><pub-id pub-id-type="pmid">38152605</pub-id>
</element-citation></ref><ref id="B48-jfmk-10-00170"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dunlap</surname><given-names>E.</given-names></name>
<name><surname>Lambeck</surname><given-names>J.</given-names></name>
<name><surname>Gobert</surname><given-names>D.</given-names></name>
</person-group><article-title>ai Chi for Balance, Pain, Functional Mobility, and Quality of Life in Adults: A scoping Review</article-title><source>J. Aquat. Phys. Ther.</source><year>2021</year><volume>29</volume><fpage>14</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1097/JAPT-D-20-00014</pub-id></element-citation></ref><ref id="B49-jfmk-10-00170"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rutz</surname><given-names>D.</given-names></name>
<name><surname>Benninger</surname><given-names>D.</given-names></name>
</person-group><article-title>Physical Therapy for Freezing of Gait and Gait Impairments in Parkinson Disease: A systematic Review</article-title><source>PM R</source><year>2020</year><volume>12</volume><fpage>1140</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1002/pmrj.12337</pub-id><pub-id pub-id-type="pmid">31994842</pub-id>
</element-citation></ref><ref id="B50-jfmk-10-00170"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Volpe</surname><given-names>D.</given-names></name>
<name><surname>Pavan</surname><given-names>D.</given-names></name>
<name><surname>Morris</surname><given-names>M.</given-names></name>
<name><surname>Guiotto</surname><given-names>A.</given-names></name>
<name><surname>Lansek</surname><given-names>R.</given-names></name>
<name><surname>Fortuna</surname><given-names>S.</given-names></name>
<name><surname>Frazzitta</surname><given-names>G.</given-names></name>
<name><surname>Sawacha</surname><given-names>Z.</given-names></name>
</person-group><article-title>under water gait analysis in Parkinson&#x02019;s disease</article-title><source>Gait Posture</source><year>2017</year><volume>52</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.gaitpost.2016.11.019</pub-id><pub-id pub-id-type="pmid">27888696</pub-id>
</element-citation></ref><ref id="B51-jfmk-10-00170"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nutt</surname><given-names>J.</given-names></name>
<name><surname>Bloem</surname><given-names>B.</given-names></name>
<name><surname>Giladi</surname><given-names>N.</given-names></name>
<name><surname>Hallet</surname><given-names>M.</given-names></name>
<name><surname>Horak</surname><given-names>F.</given-names></name>
<name><surname>Nieuwboew</surname><given-names>A.</given-names></name>
</person-group><article-title>Freezing of gait: Moving forward on a mysterious clinical phenomenon</article-title><source>Lancet Neurol.</source><year>2011</year><volume>10</volume><fpage>734</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(11)70143-0</pub-id><pub-id pub-id-type="pmid">21777828</pub-id>
</element-citation></ref><ref id="B52-jfmk-10-00170"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huh</surname><given-names>Y.</given-names></name>
<name><surname>Hwang</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>K.</given-names></name>
<name><surname>Chung</surname><given-names>W.</given-names></name>
<name><surname>Youn</surname><given-names>J.</given-names></name>
<name><surname>Cho</surname><given-names>J.</given-names></name>
</person-group><article-title>Postural sensory correlates of freezing of gait in Parkinson&#x02019;s Disease</article-title><source>Park. Relat. Disord.</source><year>2016</year><volume>25</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2016.02.004</pub-id></element-citation></ref><ref id="B53-jfmk-10-00170"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gomes Neto</surname><given-names>M.</given-names></name>
<name><surname>Pontes</surname><given-names>S.</given-names></name>
<name><surname>Almeida</surname><given-names>L.</given-names></name>
<name><surname>Da Silva</surname><given-names>C.</given-names></name>
<name><surname>da Conceicao Sena</surname><given-names>C.</given-names></name>
<name><surname>Saquetto</surname><given-names>M.</given-names></name>
</person-group><article-title>Effects of water-based exercise on functioning and quality of life in people with Parkinson&#x02019;s disease: A systematic review and meta-analysis</article-title><source>Clin. Rehabil.</source><year>2020</year><volume>34</volume><fpage>1425</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1177/0269215520943660</pub-id><pub-id pub-id-type="pmid">32715810</pub-id>
</element-citation></ref><ref id="B54-jfmk-10-00170"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liposcki</surname><given-names>D.</given-names></name>
<name><surname>da Silva</surname><given-names>I.</given-names></name>
<name><surname>Silvano</surname><given-names>G.</given-names></name>
<name><surname>Zanella</surname><given-names>K.</given-names></name>
<name><surname>Schneider</surname><given-names>R.</given-names></name>
</person-group><article-title>Influence of a Pilates exercise program on the quality of life of sedentary elderly people: A randomized clinical trial</article-title><source>J. Bodyw. Mov. Ther.</source><year>2019</year><volume>23</volume><fpage>390</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.jbmt.2018.02.007</pub-id><pub-id pub-id-type="pmid">31103125</pub-id>
</element-citation></ref><ref id="B55-jfmk-10-00170"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>da Silva</surname><given-names>L.</given-names></name>
<name><surname>Tortelli</surname><given-names>L.</given-names></name>
<name><surname>Motta</surname><given-names>J.</given-names></name>
<name><surname>Menguer</surname><given-names>L.</given-names></name>
<name><surname>Marinano</surname><given-names>S.</given-names></name>
<name><surname>Tasca</surname><given-names>G.</given-names></name>
<name><surname>Silveira</surname><given-names>G.</given-names></name>
<name><surname>Pinho</surname><given-names>R.</given-names></name>
<name><surname>Silveira</surname><given-names>P.</given-names></name>
</person-group><article-title>Effects of aquatic exercise on mental health, functional autonomy and oxidative stress in depressed elderly individuals: A randomized cl&#x000ed;nical trial</article-title><source>Clinics</source><year>2019</year><volume>74</volume><fpage>e322</fpage><pub-id pub-id-type="doi">10.6061/clinics/2019/e322</pub-id><pub-id pub-id-type="pmid">31271585</pub-id>
</element-citation></ref><ref id="B56-jfmk-10-00170"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>da Silva</surname><given-names>L.</given-names></name>
<name><surname>Menguer</surname><given-names>L.</given-names></name>
<name><surname>Doyenart</surname><given-names>R.</given-names></name>
<name><surname>Boeira</surname><given-names>D.</given-names></name>
<name><surname>Milhomens</surname><given-names>Y.</given-names></name>
<name><surname>Dieke</surname><given-names>B.</given-names></name>
<name><surname>Volpato</surname><given-names>A.</given-names></name>
<name><surname>Thirupathi</surname><given-names>A.</given-names></name>
<name><surname>Silveira</surname><given-names>P.</given-names></name>
</person-group><article-title>Effect of aquatic exercise on menthal health, functional autonomy, and oxidative damages in diabetes elderly individuals</article-title><source>Int. J. Enviorn. Health Res.</source><year>2022</year><volume>32</volume><fpage>2098</fpage><lpage>2111</lpage><pub-id pub-id-type="doi">10.1080/09603123.2021.1943324</pub-id></element-citation></ref><ref id="B57-jfmk-10-00170"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yaremchuk</surname><given-names>K.</given-names></name>
</person-group><article-title>Sleep Disorders in Elderly</article-title><source>Clin. Geriatr. Med.</source><year>2018</year><volume>34</volume><fpage>205</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.cger.2018.01.008</pub-id><pub-id pub-id-type="pmid">29661333</pub-id>
</element-citation></ref><ref id="B58-jfmk-10-00170"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frohnhofen</surname><given-names>H.</given-names></name>
<name><surname>Popp</surname><given-names>R.</given-names></name>
<name><surname>Stieglitz</surname><given-names>S.</given-names></name>
<name><surname>Netzer</surname><given-names>N.</given-names></name>
<name><surname>Danker-Hopfe</surname><given-names>H.</given-names></name>
</person-group><article-title>Assessment of sleep and sleep disorders in geriatric patients</article-title><source>Z. Gerontol. Geriatr.</source><year>2020</year><volume>53</volume><fpage>100</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1007/s00391-019-01670-9</pub-id><pub-id pub-id-type="pmid">31863167</pub-id>
</element-citation></ref><ref id="B59-jfmk-10-00170"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martins</surname><given-names>D.</given-names></name>
<name><surname>Brito</surname><given-names>R.</given-names></name>
<name><surname>Stramosk</surname><given-names>J.</given-names></name>
<name><surname>Batisti</surname><given-names>A.</given-names></name>
<name><surname>Madeira</surname><given-names>F.</given-names></name>
<name><surname>Turnes</surname><given-names>B.</given-names></name>
<name><surname>Mazzardo-Martins</surname><given-names>L.</given-names></name>
<name><surname>Santos</surname><given-names>A.</given-names></name>
<name><surname>Piovezan</surname><given-names>A.</given-names></name>
</person-group><article-title>Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflamatory pain</article-title><source>J. Neurosci. Res.</source><year>2015</year><volume>93</volume><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1002/jnr.23461</pub-id><pub-id pub-id-type="pmid">25079058</pub-id>
</element-citation></ref><ref id="B60-jfmk-10-00170"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bayraktar</surname><given-names>D.</given-names></name>
<name><surname>Guclu-Gunduz</surname><given-names>A.</given-names></name>
<name><surname>Yazici</surname><given-names>G.</given-names></name>
<name><surname>Lambeck</surname><given-names>J.</given-names></name>
<name><surname>Batur-Caglayan</surname><given-names>H.</given-names></name>
<name><surname>Irkec</surname><given-names>C.</given-names></name>
<name><surname>Nazliel</surname><given-names>B.</given-names></name>
</person-group><article-title>Effects of Ai-Chi on balance, functional movility, strength and fatigue in patients with multiple sclerosis: A pilot study</article-title><source>NeuroRehabilitation</source><year>2013</year><volume>33</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.3233/NRE-130974</pub-id><pub-id pub-id-type="pmid">23949074</pub-id>
</element-citation></ref><ref id="B61-jfmk-10-00170"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prado</surname><given-names>A.</given-names></name>
<name><surname>Reichert</surname><given-names>T.</given-names></name>
<name><surname>Concei&#x000e7;ao</surname><given-names>M.</given-names></name>
<name><surname>Delevatti</surname><given-names>R.</given-names></name>
<name><surname>Kanitz</surname><given-names>A.</given-names></name>
<name><surname>Kruel</surname><given-names>L.</given-names></name>
</person-group><article-title>Effects of Aquatic Exercise on Muscle Strength in Young and Elderly Adults: A Systematic Review and Meta-Analysis of Ranzomized Trials</article-title><source>J. Strength Cond. Res.</source><year>2022</year><volume>36</volume><fpage>1468</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1519/JSC.0000000000001595</pub-id><pub-id pub-id-type="pmid">27575248</pub-id>
</element-citation></ref><ref id="B62-jfmk-10-00170"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scalzo</surname><given-names>P.</given-names></name>
<name><surname>K&#x000fc;mmer</surname><given-names>A.</given-names></name>
<name><surname>Bretas</surname><given-names>T.L.</given-names></name>
<name><surname>Cardoso</surname><given-names>F.</given-names></name>
<name><surname>Teixeira</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson&#x02019;s disease</article-title><source>J. Neurol.</source><year>2010</year><volume>257</volume><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1007/s00415-009-5357-2</pub-id><pub-id pub-id-type="pmid">19847468</pub-id>
</element-citation></ref><ref id="B63-jfmk-10-00170"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Szuhany</surname><given-names>K.L.</given-names></name>
<name><surname>Bugatti</surname><given-names>M.</given-names></name>
<name><surname>Otto</surname><given-names>M.W.</given-names></name>
</person-group><article-title>A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor</article-title><source>J. Psychiatr. Res.</source><year>2015</year><volume>60</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2014.10.003</pub-id><pub-id pub-id-type="pmid">25455510</pub-id>
</element-citation></ref><ref id="B64-jfmk-10-00170"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cefis</surname><given-names>M.</given-names></name>
<name><surname>Chaney</surname><given-names>R.</given-names></name>
<name><surname>Wirtz</surname><given-names>J.</given-names></name>
<name><surname>M&#x000e9;loux</surname><given-names>A.</given-names></name>
<name><surname>Quiri&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Leger</surname><given-names>C.</given-names></name>
<name><surname>Prigent-Tessier</surname><given-names>A.</given-names></name>
<name><surname>Garnier</surname><given-names>P.</given-names></name>
</person-group><article-title>Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction</article-title><source>Front. Mol. Neurosci.</source><year>2023</year><volume>16</volume><elocation-id>1275924</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2023.1275924</pub-id><pub-id pub-id-type="pmid">37868812</pub-id>
</element-citation></ref><ref id="B65-jfmk-10-00170"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wrann</surname><given-names>C.D.</given-names></name>
<name><surname>White</surname><given-names>J.P.</given-names></name>
<name><surname>Salogiannnis</surname><given-names>J.</given-names></name>
<name><surname>Laznik-Bogoslavski</surname><given-names>D.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Ma</surname><given-names>D.</given-names></name>
<name><surname>Lin</surname><given-names>J.D.</given-names></name>
<name><surname>Greenberg</surname><given-names>M.E.</given-names></name>
<name><surname>Spiegelman</surname><given-names>B.M.</given-names></name>
</person-group><article-title>Exercise Induces Hippocampal BDNF through a PGC-1&#x003b1;/FNDC5 Pathway</article-title><source>Cell Metab.</source><year>2013</year><volume>18</volume><fpage>649</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.09.008</pub-id><pub-id pub-id-type="pmid">24120943</pub-id>
</element-citation></ref><ref id="B66-jfmk-10-00170"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kang</surname><given-names>D.W.</given-names></name>
<name><surname>Bressel</surname><given-names>E.</given-names></name>
<name><surname>Kim</surname><given-names>D.Y.</given-names></name>
</person-group><article-title>Effects of aquatic exercise on insulin-like growth factor-1, brain-derived neurotrophic factor, vascular endothelial growth factor, and cognitive function in elderly women</article-title><source>Exp. Gerontol.</source><year>2020</year><volume>132</volume><fpage>110842</fpage><pub-id pub-id-type="doi">10.1016/j.exger.2020.110842</pub-id><pub-id pub-id-type="pmid">31954186</pub-id>
</element-citation></ref><ref id="B67-jfmk-10-00170"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hirsch</surname><given-names>M.A.</given-names></name>
<name><surname>van Wegen</surname><given-names>E.E.H.</given-names></name>
<name><surname>Newman</surname><given-names>M.A.</given-names></name>
<name><surname>Heyn</surname><given-names>P.C.</given-names></name>
</person-group><article-title>Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson&#x02019;s disease: A systematic review and meta-analysis</article-title><source>Transl. Neurodegener.</source><year>2018</year><volume>7</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/s40035-018-0112-1</pub-id><pub-id pub-id-type="pmid">29568518</pub-id>
</element-citation></ref><ref id="B68-jfmk-10-00170"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farinha</surname><given-names>C.</given-names></name>
<name><surname>Ferreira</surname><given-names>J.P.</given-names></name>
<name><surname>Serrano</surname><given-names>J.</given-names></name>
<name><surname>Santos</surname><given-names>H.</given-names></name>
<name><surname>Oliveiros</surname><given-names>B.</given-names></name>
<name><surname>Silva</surname><given-names>F.M.</given-names></name>
<name><surname>Cascante-Rusenhack</surname><given-names>M.</given-names></name>
<name><surname>Teixeira</surname><given-names>A.M.</given-names></name>
</person-group><article-title>The impact of aquatic exercise programs on the systemic hematological and inflammatory markers of community dwelling elderly: A randomized controlled trial</article-title><source>Front. Physiol.</source><year>2022</year><volume>13</volume><elocation-id>838580</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2022.838580</pub-id><pub-id pub-id-type="pmid">36246130</pub-id>
</element-citation></ref><ref id="B69-jfmk-10-00170"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ortega</surname><given-names>E.</given-names></name>
<name><surname>Bote</surname><given-names>M.E.</given-names></name>
<name><surname>Giraldo</surname><given-names>E.</given-names></name>
<name><surname>Garc&#x000ed;a</surname><given-names>J.J.</given-names></name>
<name><surname>Ortega</surname><given-names>E.</given-names></name>
<name><surname>Bote</surname><given-names>M.E.</given-names></name>
<name><surname>Giraldo</surname><given-names>E.</given-names></name>
<name><surname>Garc&#x000ed;a</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients</article-title><source>Scand. J. Med. Sci. Sport.</source><year>2012</year><volume>22</volume><fpage>104</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0838.2010.01132.x</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jfmk-10-00170-f001"><label>Figure 1</label><caption><p>Flow chart of study selection for the literature review (PRISMA) [<xref rid="B27-jfmk-10-00170" ref-type="bibr">27</xref>].</p></caption><graphic xlink:href="jfmk-10-00170-g001" position="float"/></fig><fig position="float" id="jfmk-10-00170-f002"><label>Figure 2</label><caption><p>Summary of the results obtained. Abbreviations. &#x02191; Statistically significant improvements (<italic toggle="yes">p</italic> &#x0003c; 0.05); &#x02194; No statistically significant difference (<italic toggle="yes">p</italic> &#x0003e; 0.05); CG: control group; IG: intervention group; QoL: Quality of life. Authors. 1. Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>], 2. Kurt et al. [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>], 3. Loureiro et al. [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>], 4. Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>], 5. Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>], 6. Palamara et al. [<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>], 7. P&#x000e9;rez de la Cruz [<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>], 8. P&#x000e9;rez de la Cruz [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>], 9. P&#x000e9;rez de la Cruz [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>], 10. Shahmohammadi et al. [<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>], 11. Terrens et al. [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>], 12. Volpe et al. [<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>], 13. Volpe et al. [<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>].</p></caption><graphic xlink:href="jfmk-10-00170-g002" position="float"/></fig><fig position="float" id="jfmk-10-00170-f003"><label>Figure 3</label><caption><p>Results of risk of bias assessment of included studies&#x02014;Cochrane tool [<xref rid="B30-jfmk-10-00170" ref-type="bibr">30</xref>].</p></caption><graphic xlink:href="jfmk-10-00170-g003" position="float"/></fig><fig position="float" id="jfmk-10-00170-f004"><label>Figure 4</label><caption><p>Proposed protocol for aquatic therapy in patients with Parkinson&#x02019;s Disease.</p></caption><graphic xlink:href="jfmk-10-00170-g004" position="float"/></fig><table-wrap position="float" id="jfmk-10-00170-t001"><object-id pub-id-type="pii">jfmk-10-00170-t001_Table 1</object-id><label>Table 1</label><caption><p>Results of methodological quality assessment of included studies of Critical Appraisal Skills Program (CASPe) [<xref rid="B29-jfmk-10-00170" ref-type="bibr">29</xref>].</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Study</th><th colspan="11" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Item</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Total</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>]<break/>2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kurt et al. [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>]<break/>2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loureiro et al. [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>] 2022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>] 2024</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>] 2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palamara et al. [<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>] 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>] 2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>] 2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shahmohammadi et al. [<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>] 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terrens et al. [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>] 2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volpe et al. [<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>]<break/>2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volpe et al. [<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>]<break/>2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &#x0003c; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr></tbody></table><table-wrap-foot><fn><p>CASPe questionnaire items. 1: clearly defined question; 2: random assignment; 3: patients considered until the end; 4: blinding; 5: similar groups at baseline; 6: equally treated groups; 7: longer treatment effect; 8: accuracy of effect; 9: applicability to your setting or local population; 10: all outcomes considered; 11: benefits justify risk and cost. Abbreviations. B: big; M: medium; S: small.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jfmk-10-00170-t002"><object-id pub-id-type="pii">jfmk-10-00170-t002_Table 2</object-id><label>Table 2</label><caption><p>Summary of studies included in the systematic review&#x02014;participants, intervention characteristics, outcomes, and results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">First Author, Year, and Country of Publication</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Desing</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Participants (Baseline Sample Side and Characteristics)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcomes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>], 2019 Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 60 (8 dropouts &#x02192; n<sub>f</sub> = 52); 13 &#x02640; and 39 &#x02642;. 2&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 30 (3 dropouts &#x02192; n<sub>f</sub> = 27); 8 &#x02640; and 19 &#x02642;.<break/>Age (mean &#x000b1; SD) = 67 &#x000b1; 8 years <break/>CG:<break/>n<sub>i</sub> = 30 (5 dropouts &#x02192; n<sub>f</sub> = 25); 5 &#x02640; and 20 &#x02642;.<break/>Age (mean &#x000b1; SD) = 67 &#x000b1; 11 years </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG:<break/>4-week aquatic exercise program and intensive multidisciplinary rehabilitation program.<break/>CG: <break/>4-week intensive multidisciplinary rehabilitation program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balance: BBS<break/>Gait: TUG and FOGQ<break/>Aerobic capacity: 6MWT<break/>QoL: UPDRS II and UPDRS III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>(d = 0.8)<break/>BBS: MD = 7.33 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>TUG: MD = &#x02212;3.88 s; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>FOGQ: MD = &#x02212;5.48 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>6MWT: MD = 86 m; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>UPDRS II: MD = &#x02212;4.85 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>UPDRS III: MD = &#x02212;6.26 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>IG vs. CG<break/>(d = 0.8)<break/>BBS: MD = &#x02212;0.23 points; <italic toggle="yes">p</italic> = 0.88<break/>TUG: MD = &#x02212;0.63 s; <italic toggle="yes">p</italic> = 0.57<break/>FOGQ: MD = 0.36 points; <italic toggle="yes">p</italic> = 0.58<break/>6MWT: MD = 22 m; <italic toggle="yes">p</italic> = 0.19<break/>UPDRS II: MD = &#x02212;0.49 points; <italic toggle="yes">p</italic> = 0.41<break/>UPDRS III: MD = &#x02212;0.58 points; <italic toggle="yes">p</italic> = 0.42</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kurt et al. [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>] <break/>2018 Turkey </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 40 (0 dropouts &#x02192; n<sub>f</sub> = 40); 16 &#x02640; and 24 &#x02642;. 2&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 20 (0 dropouts &#x02192; n<sub>f</sub> = 20); 9 &#x02640; and 11 &#x02642;.<break/>Age (mean &#x000b1; SD) = 62.41 &#x000b1; 6.76 years <break/>GC:<break/>n<sub>i</sub> = 20 (0 dropouts &#x02192; n<sub>f</sub> = 20); 7 &#x02640; and 13 &#x02642;.<break/>Age (mean &#x000b1; SD) = 63.61 &#x000b1; 7.18 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>5-week Ai Chi program.<break/>CG: <break/>5-week land-based exercise program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balance: Biodex (API, MLI, OBI) and BBS<break/>Gait: TUG<break/>QoL: PDQ-39 and UPDRS-III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>(d = 0.8)<break/>API: MD = &#x02212;0.5; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>MLI: MD = &#x02212;0.3; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>OBI: MD = &#x02212;0.5; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>BBS: MD = 4.41 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>TUG: MD = &#x02212;5.01 s; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>PDQ-39: MD = &#x02212;4 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>UPDRS-III: MD = &#x02212;3.29 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>IG vs. CG<break/>(d = 0.8)<break/>API: MD = &#x02212;0.4; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>MLI: MD = &#x02212;0.15; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>OBI: MD = &#x02212;0.62; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>BBS: MD = 2.5 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>TUG: MD = &#x02212;3.96 s; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>PDQ-39: MD = &#x02212;3 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>UPDRS-III: MD = &#x02212;1.41 points; <italic toggle="yes">p</italic> &#x0003c; 0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loureiro et al. [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>]<break/>2022 Brazil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 35 (7 dropouts &#x02192; n<sub>f</sub> = 28); 12 &#x02640; and 16 &#x02642;. 1&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 18 (4 dropouts &#x02192; n<sub>f</sub> = 14); 6 &#x02640; and 8 &#x02642;.<break/>Age (median (IQR)) = 69.0 (11.0) years <break/>CG:<break/>n<sub>i</sub> = 17 (3 dropouts &#x02192; n<sub>f</sub> = 14); 6 &#x02640; and 8 &#x02642;.<break/>Age (median (IQR)) = 63.0 (5.8) years </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>9-week WATSU program and land-based exercise program.<break/>CG: <break/>9-week land-based exercise program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">QoL: NHP<break/>Sleep quality: PSQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>NHP: MD = 12 points; <italic toggle="yes">p</italic> = 0.001; d = 0.87<break/>PDQI: MD = 6 points; <italic toggle="yes">p</italic> = 0.001; d = 0.85<break/>IG vs. CG<break/>NHP: MD = 13 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.68<break/>PSQI: MD = 5.5 points; <italic toggle="yes">p</italic> &#x0003c; 0.01; d = 0.78</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>] 2024 Brazil and Ireland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 94 (11 dropouts &#x02192; n<sub>f</sub> = 83); 33 &#x02640; and 50 &#x02642;. 1&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 22 (1 dropout &#x02192; n<sub>f</sub> = 21); 4 &#x02640; and 17 &#x02642;.<break/>Age (mean &#x000b1; SD) = 66.76 &#x000b1; 8.97 years<break/>CG:<break/>n<sub>i</sub> = 37 (6 dropout &#x02192; n<sub>f</sub> = 31); 8 &#x02640; and 23 &#x02642;.<break/>Age (mean &#x000b1; SD) = 67.87 &#x000b1; 11.20 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>12-week aquatic exercise program. <break/>CG:<break/>12-week Nordic walking program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Falls: FES<break/>Gait: TUG <break/>Aerobic capacity: 6MWT<break/>Strength: STS and manual dynamometry<break/>QoL: PDQ-39 and UPDRS III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>FES: MD = 2.19 points; <italic toggle="yes">p</italic> &#x0003e; 0.05; d = 0.23<break/>TUG: MD = 0.46 s; <italic toggle="yes">p</italic> &#x0003e; 0.05; d = 0.07<break/>6MWT: MD = 22.37 m; <italic toggle="yes">p</italic> &#x0003e; 0.05; d = 0.24<break/>STS: MD = &#x02212;1.27 s; <italic toggle="yes">p</italic> &#x0003e; 0.05; d = 0.16<break/>Manual dynamometry: MD = &#x02212;0.81 kg; <italic toggle="yes">p</italic> &#x0003e; 0.05; d = 0.04<break/>PDQ-39: MD = 0.86 points; <italic toggle="yes">p</italic> &#x0003e; 0.05; d = 0.05<break/>UPDRS III: MD = 1.53 points; <italic toggle="yes">p</italic> &#x0003e; 0.05; d = 0.25<break/>IG vs. CG<break/>FES: MD = 0.06 points<break/>TUG: MD = 0.16 s<break/>6MWT: MD = &#x02212;3.41 m<break/>STS: MD = &#x02212;2.36 s<break/>Manual dynamometry: MD = 0.43 kg<break/>PDQ-39: MD = 4.96 points<break/>UPDRS III: MD = 1.04 points</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]<break/>2018 South Africa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 43 (8 dropouts &#x02192; n<sub>f</sub> = 35). 1&#x02013;3 H&#x00026;Y stage. Medication ON<break/>Age (mean &#x000b1; SD) = 65.2 &#x000b1; 9.85 years<break/>IG:<break/>n<sub>i</sub> = 23 (6 dropouts &#x02192; n<sub>f</sub> = 17)<break/>CG:<break/>n<sub>i</sub> = 20 (2 dropouts &#x02192; n<sub>f</sub> = 18)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>12-week aquatic exercise program.<break/>CG: <break/>12-week land-based exercise program. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Posture: kyphosis<break/>Balance: BBS<break/>Gait: TUG and speed 10 m<break/>Strength: STS, knee and ankle isometric, manual dynamometry, knee isokinetic (quadriceps-hamstring relation) <break/>Flexibility: SLRT and shoulder ROM<break/>Mental health: MHC, BDI and MBCBA.<break/>QoL: UPDRS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>Kyphosis: MD = 1; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>BBS: MD = 2 points; <italic toggle="yes">p</italic> = 0.003<break/>TUG: MD = 1 s; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>Speed 10 m: MD = 0.3 m/s; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>STS: MD = 2 reps; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>Knee isometric: MD = 1.3 kg; <italic toggle="yes">p</italic> = 0.091<break/>Ankle isometric: MD = 2.6 kg; <italic toggle="yes">p</italic> = 0.004<break/>Manual dynamometry: MD = 2.5 kg; <italic toggle="yes">p</italic> = 0.021<break/>Knee isokinetic: MD = 8%; <italic toggle="yes">p</italic> = 0.036<break/>SLRT: MD = 7&#x000b0;; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>Shoulder ROM: <italic toggle="yes">p</italic> &#x0003e; 0.05 flexion and extension<break/>MHC: <italic toggle="yes">p</italic> &#x0003e; 0.05 in all sections<break/>BDI: MD = &#x02212;4 points; <italic toggle="yes">p</italic> = 0.003<break/>MBCBA: <italic toggle="yes">p</italic> &#x0003e; 0.05 in all sections<break/>UPDRS: MD = &#x02212;13 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>IG vs. CG<break/>Kyphosis: MD = &#x02212;4; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>BBS: MD = 0 points; <italic toggle="yes">p</italic> = 0.352<break/>TUG: MD = 0 s; <italic toggle="yes">p</italic> = 0.998<break/>Speed 10 m: MD = 0 m/s; <italic toggle="yes">p</italic> = 0.999<break/>STS: MD = &#x02212;1 reps; <italic toggle="yes">p</italic> = 0.971<break/>Knee isometric: MD = &#x02212;0.1 kg; <italic toggle="yes">p</italic> = 0.116<break/>Ankle isometric: MD = &#x02212;0.4 kg; <italic toggle="yes">p</italic> = 0.663<break/>Manual dynamometry: MD = 2.9 kg; <italic toggle="yes">p</italic> = 0.603<break/>Knee isokinetic: MD = 1%; <italic toggle="yes">p</italic> = 0.363<break/>SLRT: MD = 3&#x000b0;; <italic toggle="yes">p</italic> = 0.015<break/>Shoulder ROM: <italic toggle="yes">p</italic> &#x0003e; 0.05 flexion and extension<break/>MHC: <italic toggle="yes">p</italic> &#x0003e; 0.05 in all sections<break/>BDI: MD = &#x02212;1 points; <italic toggle="yes">p</italic> = 0.771<break/>MBCBA: <italic toggle="yes">p</italic> &#x0003e; 0.05 in all sections<break/>UPDRS: MD = 0; <italic toggle="yes">p</italic> = 0.629</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palamara et al. [<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] 2017, Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 34 (0 dropouts &#x02192; n<sub>f</sub> = 34); 14 &#x02640; and 20 &#x02642;. 2,5&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 17 (0 dropouts &#x02192; n<sub>f</sub> = 17); 8 &#x02640; and 9 &#x02642;.<break/>Age (mean &#x000b1; SD) = 70.9 &#x000b1; 5.7 years <break/>CG:<break/>n<sub>i</sub> = 17 (0 dropouts &#x02192; n<sub>f</sub> = 17); 6 &#x02640; and 11 &#x02642;.<break/>Age (mean &#x000b1; SD) = 70.8 &#x000b1; 5.3 years </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG:<break/>4-week aquatic exercise program and intensive, multidisciplinary rehabilitation program.<break/>CG: <break/>4-week intensive multidisciplinary rehabilitation program. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balance: BBS<break/>Gait: TUG<break/>QoL: UPDRS II and UPDRS III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>(d = 0.8)<break/>BBS: MD = 7.8 points; <italic toggle="yes">p</italic> = 0.0001<break/>TUG: MD = &#x02212;3.45 s; <italic toggle="yes">p</italic> = 0.001<break/>UPDRS II: MD = &#x02212;5.1 points; <italic toggle="yes">p</italic> = 0.0005<break/>UPDRS III: MD = &#x02212;6 points; <italic toggle="yes">p</italic> = 0.0009 <break/>IG vs. CG<break/>(d = 0.8)<break/>BBS: MD = 0.5 points; <italic toggle="yes">p</italic> = 0.99<break/>TUG: MD = &#x02212;1 s; <italic toggle="yes">p</italic> = 0.99<break/>UPDRS II: MD = 1 points; <italic toggle="yes">p</italic> = 0.88<break/>UPDRS III: MD = 1 points; <italic toggle="yes">p</italic> = 0.99</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>] 2017 Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 30 (0 dropouts &#x02192; n<sub>f</sub> = 30); 16 &#x02640; and 14 &#x02642;. 1&#x02013;3 H&#x00026;Y stage. Medication OFF<break/>IG:<break/>n<sub>i</sub> = 15 (0 dropouts &#x02192; n<sub>f</sub> = 15).<break/>Age (mean &#x000b1; SD) = 66.80 &#x000b1; 5.26 years <break/>CG:<break/>n<sub>i</sub> = 15 (0 dropouts &#x02192; n<sub>f</sub> = 15).<break/>Age (mean &#x000b1; SD) = 67.53 &#x000b1; 9.89 years </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>10-week Ai Chi program. <break/>CG: <break/>10-week land-based exercise program. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain: VAS <break/>Balance: BBS<break/>Gait: TUG and Tinetti <break/>Strength: STS<break/>QoL: UPDRS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>VAS: MD = &#x02212;1.4 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.487<break/>BBS: MD = 4.1 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.412<break/>TUG: MD = &#x02212;2.5 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.295<break/>Tinetti: MD = 2.6 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.314<break/>STS: MD = &#x02212;1.7 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.225<break/>UPDRS: MD = 0 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.516<break/>IG vs. CG<break/>VAS: MD = &#x02212;0.9 points; <italic toggle="yes">p</italic> = 0.005; d = 0.233<break/>BBS: MD = 4.1 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.412<break/>TUG: MD = &#x02212;2.5 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.295<break/>Tinetti: MD = 2.9 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.418<break/>STS: MD = &#x02212;1.6 s; <italic toggle="yes">p</italic> = 0.006; d = 0.177<break/>UPDRS: MD = 0.4 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.453</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>] 2018 Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 29 (0 dropouts &#x02192; n<sub>f</sub> = 29); 17 &#x02640; and 12 &#x02642;. 1&#x02013;3 H&#x00026;Y stage. Medication OFF<break/>IG:<break/>n<sub>i</sub> = 14 (0 dropouts &#x02192; n<sub>f</sub> = 14); 9 &#x02640; and 5 &#x02642;. <break/>Age (mean &#x000b1; SD) = 65.87 &#x000b1; 7.09 years <break/>CG:<break/>n<sub>i</sub> = 15 (0 dropouts &#x02192; n<sub>f</sub> = 15); 8 &#x02640; and 7 &#x02642;.<break/>Age (mean &#x000b1; SD) = 66.44 &#x000b1; 5.72 years </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>11-week Ai Chi program.<break/>CG: <break/>11-week land-based exercise program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain: VAS<break/>Balance: monopodal balance<break/>Gait: TUG<break/>Strength: STS<break/>Mental Health: GDS<break/>QoL: PDQ-39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>VAS: MD = &#x02212;1.4 points; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.489<break/>Right monopodal balance; MD = 4.2 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.495<break/>Left monopodal balance: MD = 2.94 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.392<break/>TUG: MD = &#x02212;2 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.284<break/>STS: MD = &#x02212;1.6 s; <italic toggle="yes">p</italic> = 0.001; d = 0.233<break/>GDS: MD = &#x02212;0.14 points; <italic toggle="yes">p</italic> = 0.001; d = 0.279<break/>PDQ-39: <italic toggle="yes">p</italic> &#x0003e; 0.05 in all sections except social support<break/>IG vs. CG<break/>VAS: MD = &#x02212;1 point; <italic toggle="yes">p</italic> = 0.005; d = 0.248<break/>Right monopodal balance: MD = 4.27 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.516<break/>Left monopodal balance: MD = 3 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.390<break/>TUG: MD = &#x02212;1.8 s; <italic toggle="yes">p</italic> &#x0003c; 0.001; d = 0.288<break/>STS: MD = &#x02212;1.4 s; <italic toggle="yes">p</italic> = 0.006; d = 0.186<break/>GDS: MD = 0.06 points; <italic toggle="yes">p</italic> = 0.002; d = 0.240<break/>PDQ-39: <italic toggle="yes">p</italic> &#x0003e; 0.05 in all sections except social support</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>] 2019 Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 30 (0 dropouts &#x02192; n<sub>f</sub> = 30); 15 &#x02640; and 15 &#x02642;. 1&#x02013;3 H&#x00026;Y stage. Medication OFF<break/>IG:<break/>n<sub>i</sub> = 15 (0 dropouts &#x02192; n<sub>f</sub> = 15); 8 &#x02640; and 7 &#x02642;. <break/>Age (mean &#x000b1; SD) = 64.40 &#x000b1; 5.17 years <break/>CG:<break/>n<sub>i</sub> = 15 (0 dropouts &#x02192; n<sub>f</sub> = 15); 7 &#x02640; and 8 &#x02642;.<break/>Age (mean &#x000b1; SD) = 65.83 &#x000b1; 8.92 years </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>10-week Ai Chi program.<break/>CG: <break/>10-week land-based exercise program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain: VAS<break/>Mental health: GDS<break/>QoL: SF-36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>VAS: MD = &#x02212;1.4 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>GDS: MD = &#x02212;0.14 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>SF-36: <italic toggle="yes">p</italic> &#x02264; 0.01 in all sections<break/>IG vs. CG<break/>VAS: MD = &#x02212;1 points; <italic toggle="yes">p</italic> = 0.005<break/>GDS: MD = 0.06 points; <italic toggle="yes">p</italic> = 0.002<break/>SF-36: <italic toggle="yes">p</italic> &#x02264; 0.01 in all sections</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shahmohammadi et al. [<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>] 2017 Iran and United Kingdom</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 22 (2 dropouts &#x02192; n<sub>f</sub> = 20); 20 &#x02642;. 2&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 11 (1 dropouts &#x02192; n<sub>f</sub> = 10); 10 &#x02642;. <break/>Age (mean &#x000b1; SD) = 60.50 &#x000b1; 5.44 years <break/>CG:<break/>n<sub>i</sub> = 11 (1 dropouts &#x02192; n<sub>f</sub> = 10); 10 &#x02642;. <break/>Age (mean &#x000b1; SD) = 63.20 &#x000b1; 4.94 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>8-week aquatic exercise program. <break/>CG: <break/>8-week land-based exercise program. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balance: Postural sway evaluation in a Kistler force plate (sway range, mean speed, sway area, and mean frequency)<break/>QoL: PDQL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>(d = 0.65)<break/>Sway range: MD = 21.35 mm; <italic toggle="yes">p</italic> = 0.055<break/>Mean speed: MD = &#x02212;6.54 mm/s; <italic toggle="yes">p</italic> = 0.001<break/>Sway area: MD = 11.11 mm<sup>2</sup>/s; <italic toggle="yes">p</italic> = 0.001<break/>Mean frequency: MD = &#x02212;0.11 Hz; <italic toggle="yes">p</italic> = 0.003<break/>PDQL: MD = 21 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>IG vs. CG<break/>(d = 0.65)<break/>Sway range: MD = 8.9 mm; <italic toggle="yes">p</italic> = 0.52<break/>Mean speed; MD = &#x02212;3.6 mm/s; <italic toggle="yes">p</italic> = 0.01<break/>Sway area: MD = 12.88 mm<sup>2</sup>/s; <italic toggle="yes">p</italic> = 0.33<break/>Mean frequency: MD = &#x02212;0.13 HZ; <italic toggle="yes">p</italic> = 0.59<break/>PDQL: MD = 10.8 points; <italic toggle="yes">p</italic> &#x0003c; 0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terrens et al. [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>]<break/>Australia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 30 (5 dropouts &#x02192; n<sub>f</sub> = 25); 6 &#x02640; and 24 &#x02642;. 1&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG 1:<break/>n<sub>i</sub> = 11 (2 dropouts &#x02192; n<sub>f</sub> = 9); 1 &#x02640; and 10 &#x02642;. <break/>Age (mean &#x000b1; SD) = 74.1 &#x000b1; 6.6 years <break/>IG 2:<break/>n<sub>i</sub> = 10 (1 dropouts &#x02192; n<sub>f</sub> = 9); 3 &#x02640; and 7 &#x02642;. <break/>Age (mean &#x000b1; SD) = 65.6 &#x000b1; 7.7 years<break/>CG:<break/>n<sub>i</sub> = 9 (2 dropouts &#x02192; n<sub>f</sub> = 7); 2 &#x02640; and 7 &#x02642;. <break/>Age (mean &#x000b1; SD) = 76.4 &#x000b1; 7.4 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG 1: <break/>12-week Halliwik program.<break/>IG 2:<break/>12-week aquatic exercise program. <break/>CG:<break/>12-week land-based exercise program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balance: BBS and Mini BESTest.<break/>Falls: mFES <break/>QoL: UPDRS III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG 1: Changes from baseline<break/>BBS: MedD = 0 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>Mini-best: MedD = 8 points; <italic toggle="yes">p</italic> = 0.011<break/>mFES: MedD = 0.5 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>UPDRS III: MedD = &#x02212;1 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>IG 1 vs. CG<break/>BBS: MedD = &#x02212;1 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>Mini-Best: MedD = 10 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>mFES: MedD = &#x02212;1 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>UPDRS III: MedD = 5 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>IG 2: Changes from baseline.<break/>BBS: MedD = &#x02212;1 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>Mini-Best: MedD: &#x02212;3 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>mFES: MedD: 0.25 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>UPDRS III: MedD: 5 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>IG 2 vs. CG<break/>BBS: MedD = 0 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>Mini-best: MedD = &#x02212;1 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>mFES: MedD = &#x02212;1.25 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>UPDRS III: MedD = 14 points; <italic toggle="yes">p</italic> &#x0003e; 0.05 </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volpe et al. [<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>] 2914<break/>Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 34 (0 dropouts &#x02192; n<sub>f</sub> = 34). 2,5&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 17 (0 dropouts &#x02192; n<sub>f</sub> = 17).<break/>Age (mean &#x000b1; SD) = 68 &#x000b1; 7 years <break/>CG:<break/>n<sub>i</sub> = 17 (0 dropouts &#x02192; n<sub>f</sub> = 17).<break/>Age (mean &#x000b1; SD) = 66 &#x000b1; 8 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>8-week aquatic exercise program.<break/>CG: <break/>8-week land-based exercise program.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Balance: evaluation of the COP sway area with open and closed eyes. BBS and ABC<break/>Falls: FES y falls diary.<break/>Gait: TUG<break/>QoL: PDQ-39, UPDRS II and III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>(d = 0.8)<break/>Sway area open eyes: MD = 49.7 mm<sup>2</sup>; <italic toggle="yes">p</italic> = 0.002<break/>Sway area closed eyes: MD = 45.4 mm<sup>2</sup>; <italic toggle="yes">p</italic> = 0.010<break/>BBS: MD = 9.9 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>ABC: MD = 16.8 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>FES: MD = &#x02212;5.9 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>Falls diary: MD = &#x02212;2.4; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>TUG: MD = &#x02212;2.0 s; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>PDQ-39: MD = &#x02212;18.4 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>UPDRS II: MD = &#x02212;4.3 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>UPDRS III: MD = &#x02212;8.3 points; <italic toggle="yes">p</italic> &#x0003c; 0.0001<break/>IG vs. CG<break/>(d = 0.8)<break/>Sway area open eyes: MD = 24.3 mm<sup>2</sup>; <italic toggle="yes">p</italic> = 0.2871<break/>Sway area closed eyes: MD = 38.5 mm<sup>2</sup>; <italic toggle="yes">p</italic> = 0.0480<break/>BBS: MD = 3.9 points; <italic toggle="yes">p</italic> = 0.0046<break/>ABC: MD = 12.7 points; <italic toggle="yes">p</italic> = 0.0001<break/>FES: MD = &#x02212;4 points; <italic toggle="yes">p</italic> = 0.0026<break/>Falls diary: MD = &#x02212;2; <italic toggle="yes">p</italic> = 0.0010<break/>TUG: MD = &#x02212;0.9 s; <italic toggle="yes">p</italic> = 0.151<break/>PDQ-39: MD = &#x02212;10.4 points; <italic toggle="yes">p</italic> = 0.0063<break/>UPDRS II: MD = 0.8 points; <italic toggle="yes">p</italic> = 0.4336<break/>UPDRS III: MD = 0.1 points; <italic toggle="yes">p</italic> = 0.9381</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volpe et al. [<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>] 2016 Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n<sub>i</sub> = 30 (6 dropouts &#x02192; n<sub>f</sub> = 24); 11 &#x02640; and 19 &#x02642;. 1&#x02013;3 H&#x00026;Y stage. Medication ON<break/>IG:<break/>n<sub>i</sub> = 15 (2 dropouts &#x02192; n<sub>f</sub> = 13); 6 &#x02640; and 9 &#x02642;. <break/>Age (mean &#x000b1; SD) = 70.6 &#x000b1; 7.8 years <break/>CG:<break/>n<sub>i</sub> = 15 (4 dropouts &#x02192; n<sub>f</sub> = 11); 5 &#x02640; and 10 &#x02642;. <break/>Age (mean &#x000b1; SD) = 70 &#x000b1; 7.8 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: <break/>8-week aquatic exercise program.<break/>CG: <break/>8-week land-based exercise program. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Posture: dorsal and cervical BAK and shoulder symmetry <break/>Balance: BBS and ABC.<break/>Falls: FES<break/>Gait: TUG<break/>QoL: PDQ-39 and UPDRS III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Changes from baseline<break/>Dorsal BAK: MD = &#x02212;22.5&#x000b0;; <italic toggle="yes">p</italic> = 0.008<break/>Cervical BAK: MD = &#x02212;62.2&#x000b0;; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>Shoulder symmetry: MD = &#x02212;2.3&#x000b0;; <italic toggle="yes">p</italic> = 0.002<break/>BBS: MD = 3.5 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>ABC: MD = 8.1%; <italic toggle="yes">p</italic> = 0.02<break/>FES: MD = &#x02212;2.3 points; <italic toggle="yes">p</italic> = 0.027<break/>TUG: MD = &#x02212;1.4 s; <italic toggle="yes">p</italic> = 0.036<break/>PDQ-39: MD = &#x02212;9,6 points; <italic toggle="yes">p</italic> &#x0003c; 0.001<break/>UPDRS III: MD = &#x02212;6.1 points; <italic toggle="yes">p</italic> = 0.001 <break/>IG vs. CG<break/>Dorsal BAK: MD = &#x02212;16&#x000b0;; <italic toggle="yes">p</italic> = 0.046<break/>Cervical BAK: MD = &#x02212;66.9&#x000b0;; <italic toggle="yes">p</italic> = 0.024<break/>Shoulder symmetry: MD = &#x02212;2.6&#x000b0;; <italic toggle="yes">p</italic> = 0.047<break/>BBS: MD = &#x02212;3.4 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>ABC: MD = 5.7%; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>FES: MD = &#x02212;1 points; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>TUG: MD = 1.8 s; <italic toggle="yes">p</italic> &#x0003e; 0.05<break/>PDQ-39: MD = &#x02212;5.4 points; <italic toggle="yes">p</italic> = 0.001<break/>UPDRS: MD = &#x02212;1.1 points; <italic toggle="yes">p</italic> &#x0003e; 0.05</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations. &#x02640;: Women. &#x02642;: Men. 6MWT: 6-min walk test. ABC: Activities-specific Balance Confidence Scale. API: Anteroposterior Index. BAK: Body Analysis Kapture. BBS: Berg Balance Scale. BDI: Beck Depression Inventory. CG: Control group. COP: Centre of Pressure. d: Effect size. FES: Falls efficacy scale. FOGQ: Freezing of Gait Questionnaire. GDS: Geriatric Depression Scale. H&#x00026;Y: Hoehn and Yahr Scale. Hz: Hertz. IG: Intervention group. IQR: Interquartile rate. Kg: Kilograms. m: Metres. mm: Milimetres. MBCBA: Montgomery Borgatta Caregivers Burden Assessment. MD: Mean difference. MedD: Median difference. mFES: Modified Falls Efficacy Scale. MHC: Mental Health Continuum. MLI: Mediolateral Idex. n<sub>f</sub>: Final sample size. n<sub>i</sub>: Initial sample size. NHP: Nottingham Health Profile questionnaire. OBI: Overall balance index. PDQ-39: Parkinson&#x02019;s disease Questionaire-39. PDQL: Parkinson&#x02019;s Disease Quality of Life. PSQI: Pittsburg Sleep Quality Index. QoL: Quality of life. RCT: Randomized controlled trials. Reps: Repetitions. ROM: Range of motion. s: Seconds. SD: Standard deviation. SLRT: Straight Leg Raise Test. STS: Sit-to-stand test. TUG: Time up and go. UPDRS-III: Unified Parkinson&#x02019;s Disease Rating Scale-III. VAS: Visual Analog Scale.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jfmk-10-00170-t003"><object-id pub-id-type="pii">jfmk-10-00170-t003_Table 3</object-id><label>Table 3</label><caption><p>Characteristics of intervention group and control group interventions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author and Year</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Exercises</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Volume and Intensity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">T&#x000aa;<break/>(&#x000b0;C)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Frecuency (Days/Week)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Time<break/>(Minutes/Session)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration <break/>(Weeks)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Supervision </th></tr></thead><tbody><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>] 2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (walking in different directions, with heels, counter-resistance, and with eyes closed); Principal (proprioception, dual-task walking, obstacles and turns); Cool down (walking and stretching). All submerged in water. + CG intervention</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70&#x02013;80% reserve HR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33&#x02013;34</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 AT<break/>+<break/>CG<break/>(AT replaces session 1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Session 1 (cardiovascular warm-up, stretching, ROM work, and core and posture work). Session 2 (work on gait, balance, endurance, and motor control). Session 3 (autonomy in ADL). Session 4 (speech therapy). Day 6 (training with devices). </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70&#x02013;80% reserve HR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5<break/>(4 daily sessions)<break/>+ 1 session with devices</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Kurt et al. [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>] 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (mobility exercises); Principal (Ai Chi, 16 exercises with slow movements and deep breathing to work on balance, strength, flexibility, and breathing). Cool-down (walking and stretching). All submerged in water.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (light aerobic exercise); Principal (stretching, gait, and balance work); Cool-down (slow walking and breathing exercises).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Loureiro et al. [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>] 2022</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (recreational activities in the pool); Principal (WATSU, 12 exercises mainly in supine position); Cool-down (massage therapy in pool) + CG intervention</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.4<break/>-<break/>36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 WATSU<break/>+<break/>2 land-based</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (mobility exercises); Principal (exercises with a wide ROM, postural control, and balance); Cool-down (stretching). </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>] 2024</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (mobility exercises and stretching); Principal (running, strength exercises, balance, postural control, coordination, dual task, and diving); Cool-down (stretching and relaxation). All submerged in water.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Individualized</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (coordination); Principal (Nordic walking); Cool-down (stretching).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Individualized</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]<break/>2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (walking); Principal (gait work, joint mobility, balance, and strength exercises); Cool-down (walking and stretching). All submerged in water. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (static bicycle), Principal (gait work, joint mobility, balance, and strength exercises); Cool-down (walking and stretching)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Palamara et al. [<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] 2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (walking in different directions, with heels, counter-resistance, and with eyes closed); Principal (proprioception, dual-task walking, obstacles, and turns); Cool-down (walking and stretching). All submerged in water. + CG intervention</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70&#x02013;80% reserve HR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 AT<break/>+<break/>CG<break/>(AT replaces session 1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Session 1 (cardiovascular warm-up, stretching, ROM work, and core and posture work). Session 2 (work on gait, balance, endurance, and motor control). Session 3 (autonomy in ADL). Session 4 (speech therapy). Day 6 (training with devices).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70&#x02013;80% reserve HR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5<break/>(4 daily sessions)<break/>+ 1 session with devices</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>]<break/>2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (recreational exercises); Principal (Ai Chi, 19 exercises emphasizing reach and postural responses, trunk rotation, bipodal, and monopodal balance); Cool-down. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (mobility exercises and walking); Principal (aerobic and strength exercises); Cool-down (functional ADL exercises, balance, proprioception, facial exercises, and stretching)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>] 2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (recreational exercises); Principal (Ai Chi, 19 exercises); Cool-down.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (mobility exercises and walking); Principal (aerobic and strength exercises); Cool-down (functional ADL exercises, balance, proprioception, facial exercises, and stretching)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>] 2019</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (recreational exercises); Principal (Ai Chi, 10 exercises &#x0201c;Contemplating&#x0201d;, &#x0201c;Floating&#x0201d;, &#x0201c;Uplifting&#x0201d;, &#x0201c;Enclosing&#x0201d;, &#x0201c;Folding&#x0201d;, &#x0201c;Soothing&#x0201d;, &#x0201c;Gathering&#x0201d;, &#x0201c;Freeing&#x0201d;, &#x0201c;Shifting&#x0201d;, &#x0201c;Accepting&#x0201d;); Cool-down.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (mobility exercises and gaiting); Principal (aerobic and strength exercises); Cool down (functional ADL exercises, balance, proprioception, facial exercises, and stretching)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Shahmohammadi et al. [<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>] 2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (walking); Principal (gait work, walking in different directions, with heels, tiptoeing, and throwing a ball in different directions); Cool-down (stretching). All submerged in water. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 series of 10&#x02013;20 repetitions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (walking); Principal (gait work, walking in different directions, with heels, tiptoeing, and throwing a ball in different directions); Cool down (stretching). </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 series of 10&#x02013;20 repetitions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Terrens et al. [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>] 2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG 1: Warm-up (walking); Principal (Halliwick, balance, trunk mobility, core work, and rotations); Cool-down (stretching)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13&#x02013;14 Borg Scale</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34,7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG 2: Warm-up (walking); Principal (balance, aerobic, and strength exercises); Cool-down (stretching). All submerged in water.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13&#x02013;14 Borg Scale</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34,7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (walking); Principal (balance, aerobic, and strength exercises); Cool-down (stretching).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13&#x02013;14 Borg Scale</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Volpe et al. [<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>] 2014</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up (aerobic exercises and stretching); Principal (balance training with external disturbances, functional reach, postural responses, and strength exercises); Cool down. All submerged in water.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (aerobic exercises and stretching); Principal (balance training with external disturbances, functional reach, postural responses, and strength exercises); Cool-down. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Volpe et al. [<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>] 2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IG: Warm-up; Principal (balance training with external disturbances); Cool-down (relax exercises). All submerged in water. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CG: Warm-up (aerobic exercises and stretching); Principal (balance training with external disturbance); Cool-down (relax exercises)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not specified</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: ADL: Activities of daily living. AT: Aquatic therapy. CG: Control group. HR: Heart rate. IG: Intervention group. ROM: Range of movement. T&#x000aa;: Temperature.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jfmk-10-00170-t004"><object-id pub-id-type="pii">jfmk-10-00170-t004_Table 4</object-id><label>Table 4</label><caption><p>Results of risk of bias assessment of included studies&#x02014;Cochrane tool [<xref rid="B30-jfmk-10-00170" ref-type="bibr">30</xref>].</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Study</th><th colspan="7" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Item</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clerici et al. [<xref rid="B31-jfmk-10-00170" ref-type="bibr">31</xref>] 2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kurt et al. [<xref rid="B32-jfmk-10-00170" ref-type="bibr">32</xref>]<break/>2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loureiro et al. [<xref rid="B40-jfmk-10-00170" ref-type="bibr">40</xref>] 2022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nogueira et al. [<xref rid="B41-jfmk-10-00170" ref-type="bibr">41</xref>] 2024</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nowak [<xref rid="B42-jfmk-10-00170" ref-type="bibr">42</xref>]<break/>2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palamara et al. [<xref rid="B43-jfmk-10-00170" ref-type="bibr">43</xref>] 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B35-jfmk-10-00170" ref-type="bibr">35</xref>] 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B34-jfmk-10-00170" ref-type="bibr">34</xref>] 2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez de la Cruz [<xref rid="B33-jfmk-10-00170" ref-type="bibr">33</xref>] 2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shahmohammadi et al. [<xref rid="B36-jfmk-10-00170" ref-type="bibr">36</xref>] 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terrens et al. [<xref rid="B37-jfmk-10-00170" ref-type="bibr">37</xref>] 2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volpe et al. [<xref rid="B39-jfmk-10-00170" ref-type="bibr">39</xref>] 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volpe et al. [<xref rid="B38-jfmk-10-00170" ref-type="bibr">38</xref>]<break/>2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="jfmk-10-00170-i001.jpg"/>
</td></tr></tbody></table><table-wrap-foot><fn><p>Cochrane tool items. 1: random sequence generation; 2: assignment concealment; 3: blinding of participants and therapist; 4: blinding of assessors; 5: incomplete results data; 6: selective reporting results; 7: other biases. Abbreviations: &#x0201c;&#x02713;&#x0201d;: low risk of bias; &#x0201c;X&#x0201d;: high risk of bias&#x0201d;; &#x0201c;?&#x0201d;: uncertainty about the potential for bias or lack of information in this regard. </p></fn></table-wrap-foot></table-wrap></floats-group></article>